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1. INTRODUCTION 
 
Urolithiasis is one of the oldest disease known to human beings and has been 
documented in ancient Greek. Urinary stones have been found in the remains 
of Egyptian mummies dating back as far as 7000 years and the symptoms of 
the condition were described by Hippocrates who suggested that drinking of 
muddy river water causes the excretion of sand in urine. In those times the 
occurrence of calculi was confined to the urinary bladder and kidney stones 
were unknown. Roman physician Galen postulated that factors like diet, 
climate, hereditary, gout, race and some abnormalities cause the stone 
formation (Butt, 1956). The disease has also been described in Hindu 
medicine while muslim physicians like Razi and Avecenna have discussed the 
sign, symptoms and complications of the disease. The excretion of abnormal 
material in urine was proposed by very early scientists to be the cause of 
stone formation as it forms the nucleus of the stone which promotes the 
progressive growth. 
 
In today’s modern age also urolithiasis is affecting 3.66 million people every 
year with a huge expenditure worth $ 2 billion annually after medical bills 
(National Institute of Diabetes & Kidney Diseases, 2001). The prevalence and 
incidence are estimated to be 5-10% and 100-300/100,000/year, respectively. 
Relapses occur in 50-70% of all cases (Saita et al., 2007). At present the 
prevalence occurs in ratio of 15% in men and 6% in women. This increase is 
linked to changes in lifestyle, eating patterns and obesity. 
 
One of the major causes for acute and chronic renal failure is the stone 
formation or lithiasis which includes both nephrolithiasis (stone formation in 
kidney) and urolithiasis (stone formation in ureter or urinary bladder or both). 
 
Kidney stone is a solid lump (from as small as a grain of sand to as large as 
the size of a golf ball) made up of crystals that separate from urine and build 
up on the inner surfaces of the kidney. Kidney stones result from the 
precipitation of certain substances within the urine. In some cases, the stone 
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may not be able to travel through the ureter, causing pain and possibly an 
obstruction, blocking the flow of urine out of the kidney (Ringold et al., 2005). 
Severe  pain or aching in the back on one or both sides, sudden spasms of 
excruciating pain (renal or uteric colic), bloody, cloudy or smelly urine, feeling 
of being sick, a frequent urge to urinate, or a burning sensation during 
urination, fever and chills, etc are commonly observed symptoms in the 
patients. 
 
Supersaturation creates stone by causing ions in solution to combine with one 
another into a solid phase by nucleation. Calcium and oxalate ions can orient 
themselves on surfaces of another crystal, such as uric acid, and such 
heterogeneous nuclei may promote calcium oxalate stones. Imbalance in ratio 
of urolithiasis promoters (calcium, oxalate, uric acid and inorganic phosphate) 
and inhibitors (citrate and magnesium) and alterations in urothelial surface 
properties partly explain why only a small fraction of people form calcium 
oxalate stones though urinary calcium oxalate supersaturation is almost 
universal (NIH Consens statement, treatment & prevention. March 1998). 
Hereditary and personal history of renal stone and geographic conditions also 
influences stone formation (Ramello et al., 2000). Certain medicines such as 
diuretics (water tablets), antacids, thyroid medications, trimethoprim, 
phenytoin and sulphamethoxazole also contribute to urolithiasis. Causes of 
urolithiasis; their diversity, and the diversity of their current treatments 
complicate clinical management of patients, and offer many opportunities for 
fruitful research. 
 
Urine analysis, X-ray images, intravenous urogram and ultrasound were only 
used till now for diagnosis but now recently introduced non-contrast helical 
computerized tomography is the first-line investigational tool (Masarani et al., 
2007).  Presently crystallographic examination is one of the most precise and 
less expensive methods to identify the nature of the concretion (Saita et al., 
2007). Thiazide diuretics, allopurinol, etc are used for treatment but they have 
their own pharmacological limits and number of side effects on long term use. 
Thus, surgery is the only prime treatment of urolithiasis. Extra-corporeal shock 
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wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), Open 
surgery, Ureteroscopic stone removal method and Laparoscopic 
pyelolithotomy are surgical interventions used in various conditions. After 
spontaneous passage or surgical treatment, a subset of these patients will 
have recurrent calculi. These recurrent stone events are significantly morbid 
and can potentially lead to serious chronic renal disease, thus prevention is a 
very important treatment goal (Long et al., 2007). 
 
It is widely known that urolithiasis is characterized by high recurrence if 
patients are not treated appropriately. Despite tremendous advances 
accomplished in surgical management, by the introduction of highly 
sophisticated technologies to eliminate kidney stones, failures occur. 
Therefore, efforts are required to assess medical therapy better and develop 
new agents that can be used either alone or in combination to prevent stone 
formation efficiently in lithiasis patients. 
 
At least 600 people aged between 20 and 70 years from across the state 
Gujarat got their kidneys checked at a week-long camp organized on World 
Health Day by The Times of India and Devasya Hospital. It met with good 
response, drawing people from all classes. The common complaints were 
kidney stones, urinary tract infections (UTIs). Urologist Dr Dinesh Patel told 
TOI, "Kidney stones are common among people from Saurashtra and north 
Gujarat due to high level of total dissolved salts (TDS) in water." Other 
reasons are dietary habits - high calcium and oxalate consumption, present in 
milk products, green leafy vegetables, tomatoes, brinjals, tea and coffee, he 
added (Good response to TOI kidney camp Kevin Antao, TNN 8 April 2009, 
04:12am IST). 
 
There are many regions in Saurashtra that found to be prone to kidney stone 
disease and hence these regions are called ‘stone belt’. The increasing 
number of the people suffering from kidney related disease is evidence in 
itself of the fact that lack of awareness among the general public is now taking 
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a toll. In an interview, Dr Dinesh Patel, a urologist, lays stress on the need of 
upgrading the existing infrastructure. 
 
In about thousand villages in coastal Saurashtra(Gujarat) the TDS levels have 
risen beyond 2,000 ppm (throughout the year)  due to seawater intrusion and 
excessive groundwater extraction. They have been termed as fully saline 
villages. Seawater intrusion has changed the water quality contaminating it 
with excess salinity and different elements such as chloride, calcium, 
magnesium and sodium. This has led to prevalence of several health hazards 
in the region namely kidney stones, hypertension and skin diseases. One of 
the major reasons for kidney stones, however, is the high concentration of 
calcium in drinking water. Are port of chemical analysis of1 19 kidney stones 
prepared by an urologist in Junagadh showed that 41 percent and 48 percent 
of those had calcium-oxalateofdegree-3anddegree-2 respectively, which 
explains the presence of excess calcium in the body (Indu et al., 2000). 
Prolonged exposure to water containing salts (TDS above 500ppm) can 
cause kidney stone, a phenomenon widely reported from north and 
coastalGujarat (Kumar et al.). Indian Standard Institute confirmed permissible 
TDS as 500 mg/liter and Calcium as 75 mg/liter whereas WHO say that TDS 
should be nil and Calcium should be 50 mg/liter for drinking water. The 
average amount of TDS and Calcium found in saline villages was 2,462 
mg/liter and 296 mg/liter respectively, far beyond the maximum permissible 
limits prescribed by ISI. The corresponding figures in non-saline villages were 
345 mg/liter and 52 mg/liter respectively. In the saline villages, the average 
treatment expense incurred by an affected person was Rs. 5,790 and average 
wage loss was Rs 3,520. Urologists say that about 80 percent of kidney stone 
cases have a chance of recurrence, raising the expenses incurred on 
treatment even further. Given its high social costs, the problem of kidney 
stones, thus, deserves immediate attention from concerned authorities (Indu 
et al., 2000). 
 
‘Good health is one of the most precious assets of any population, but it 
is particularly important for populations that are poor and vulnerable.’ 
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Woodward et al. noted further in 2000 that “when ‘bread-winners’ suffers 
serious ill health or injury, entire household scan   medical care, a common 
cause of impoverishment in itself”. Thus the weak health of human resource 
will be a hurdle to the society for entire development of a region. 
 
The aim of present study was to analyze the prevalence and types of kidney 
stones in the saurashtra region and understand varied causative factors, and 
suggest possible therapy for treatment and prevention of renal calculi in 
people of saurashtra region. 
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2. LITERATURE REVIEW  
 
2.1 ANATOMY OF KIDNEY 
 
2.1.1 ANATOMY OF RENAL SYSTEM (Anatomica, 2004) 
 
The kidneys are a pair of bean shaped, red brown organ, whose function is 
to dispose of the waste matter produced by the normal functioning of the 
body and to keep the salts and water of the body in the correct balance. 
The kidneys are located at the back of the abdomen, one on each side of the 
spine, at the level of the lowest ribs. Because of the position of the liver, the 
right kidney in most people is 
located slightly lower than the left.  
Each kidney is joined with the 
ureters, the tubes that conduct urine 
to the bladder. At the centre on one 
side of each kidney is an 
indentation known as the renal 
hilus, the exit point for the ureter 
and the location where nerves, 
blood and lymphatic vessels enter 
and exit. Enclosing each kidney is a 
protective membrane, the renal 
capsule. Surrounding each capsule 
is a cushion of fatty tissue and a 
layer of connective tissue which 
attaches kidney to the back of the 
wall of the abdomen. An adrenal 
gland sits on top of each kidney. 
The   bladder   muscle   (the  detrussor muscle) is capable  of  distending  to  
accept  urine  without  increasing  the  pressure inside; this means  that  
large  volumes  can  be  collected  (700-1000ml)  without  high-pressure  
damage  to the renal  system. When urine is passed, the urethral sphincter at 
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the base of the bladder relaxes, the detrusor contracts, and urine is voided 
via the urethra.  
2.1.2 STRUCTURE OF THE KIDNEY  
Each kidney has an outer layer - the 
cortex, an inner layer – the medulla, 
and a pelvis, a hollow inner structure 
that joins with the ureters. The renal 
medulla contains between 8 and 18 
renal pyramids with a striped 
appearance. The pyramids are 
positioned with their tips, the renal 
papillae, facing towards the renal 
hilus and their bases aligned with the 
edge of the renal cortex. The cortex 
continues in between each pyramid 
creating areas known as renal columns.  
 
2.1.3 STRUCTURE OF THE NEPHRON 
The functional units of the kidneys are microscopic structures called 
nephrons, of which there are estimated to be 1.2 million in each kidney. Each 
nephron has a renal corpuscle, which lies in the renal cortex, and a renal 
tubule which runs through a renal pyramid. The renal corpuscle is comprised 
of an extensive ball shaped capillary network called the glomerulus 
surrounded by a double walled cup of epithelial tissue- the glomerular or 
Bowman’s capsule. Together, these structures filter the blood, producing a 
liquid (the filtrate) containing minerals, wastes and water.  
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The purified blood is returned to the body while the filtrate passes into the 
renal tubule, which comprises the proximal convoluted tubule, the 
descending limb of the loop of Henle, the ascending limb of the loop of Henle 
and the distal convoluted tubule. As the filtrate passes along the renal tubule, 
a network of tiny blood vessels called the peritubular capillaries reabsorbs 
useful substances from it and secretes additional wastes into it. About 99 % 
of the filtrate is reabsorbed in this way and returned to the general circulation. 
The rest 1 % or about 1 –4 liters a day – collect in the pelvis and is 
transported to the bladder as urine. 
 
If the body needs to conserve water (or needs to dilute salt in the blood), the 
kidneys return more water to the capillaries. If the body has more water than 
it need, more is excreted in the urine. In this way, the precise balance of 
water and salts in the body is maintained. Toxins, such as urea, are not 
reabsorbed but excreted in the urine and in this way the body rids itself of the 
unwanted products of the metabolism. 
 
2.2 RENAL STONES 
 
2.2.1 HISTORICAL OVERVIEW 
A kidney stone is a solid lump (from as small as a grain of sand to as large 
as the size of a golf ball) made up of crystals that separate from urine and 
build up on the inner surfaces of the kidney. 
 
Nephrolithiasis is a common disorder of the urinary tract and is a morbid and 
expensive disease. Kidney stones are responsible for about 3.66 million 
medical consults each year with treatment costing about $2 billion annually in 
medical bills (National Institute of Diabetes & 
Kidney Diseases, 2001). The prevalence and 
incidence are estimated at 5-10% and 100-
300/100,000/year, respectively. Relapses occur 
in 50-70% of all cases (Saita et al., 2007). At 
present the prevalence occurs in ratio of 15% in 
men and 6% in women. The increase is linked 
to changes in lifestyle, eating patterns and 
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obesity which has become very common. The 'metabolic syndrome' includes 
all the diseases, e.g. hypertension, lipid imbalances, type 2 diabetes mellitus, 
gout and cardiovascular disease, which are concomitant in the majority of 
stone formers. Dietary patterns, besides leading to stone formation, also 
determine stone chemistry. With a diet that is rich in oxalates, calcium 
oxalate will constitute 75% of stones, struvite 10-20%, uric acid 5-6% and 
cystine 1%. As approximately 50% of patients with stones suffer recurrences, 
metabolic and/or pharmacological prophylaxis is recommended (Porena et 
al., 2007). 
 
Kidney stones result from the precipitation (crystallization of previously 
dissolved particles) of certain substances within the urine. These stones form 
in the kidney and subsequently travel through the ureter and are eliminated 
through the urine if they are small. In some cases, the stone may not be able 
to travel through the ureter, causing pain and possibly causing an 
obstruction, blocking the flow of urine out of the kidney (Ringold et al., 2005). 
Depending on where they are located, kidney stones are also known as renal 
calculi, urinary calculi, urinary tract stone disease, nephrolithiasis, urolithiasis 
and ureterolithiasis. 
 
2.2.2 KIDNEY STONE FORMATION 
A stone can form only when urine is supersaturated with respect to its 
constituent crystals. Urine of most normal people is supersaturated with 
respect to calcium oxalate, so--in principle--all people can form such stones. 
However, normal urine is not supersaturated with respect to uric acid, cystine 
or struvite. Conditions that raise calcium oxalate supersaturation raise the 
risk of calcium oxalate stones. 
Supersaturation creates stone by causing ions in solution to combine with 
one another into a solid phase, a process called nucleation. Calcium and 
oxalate ions can orient themselves on surfaces of another crystal, such as 
uric acid, and such heterogeneous nuclei may promote calcium oxalate 
stones. The disorders that raise supersaturation and promote heterogeneous 
nucleation are the presently accepted causes of nephrolithiasis; their 
diversity and the diversity of their current treatments complicate clinical 
management of patients and offer many opportunities for fruitful research. 
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At the same time, there are other factors that may influence stone forming 
propensity, such as inhibitors of calcium oxalate crystallization and urothelial 
surface properties that affect crystal retention; variations of inhibitors and 
urothelial surface properties may partly explain why only a small fraction of 
people form calcium oxalate stones even though urinary calcium oxalate 
supersaturation is almost universal. Assessment of inhibitors and urothelial 
surface properties are not yet applicable to clinical practice, but may 
eventually transform it. (NIH Consens statement, treatment & prevention 
March 1998). 
 
Normal urinary environment is inhibitory to crystallization. Occasional crystals 
are internalized by the renal epithelial cells and sequestered to lysosomes or 
externalized into the interstitium to be handled by the inflammatory cells. 
 
Elevated levels of oxalate and calcium oxalate crystals, however, provoke 
renal cells to increase the synthesis of osteopontin, bikunin, heparan sulfate 
proteoglycan, monocyte chemoattractant protein-1, and prostaglandin E(2), 
which are known mediators of the inflammatory processes and extracellular 
matrix production. Osteopontin and bikunin are also modulators of 
crystallization. Exposed renal epithelial cells are often injured and go through 
apoptosis and/or necrosis initiating a cascade of events leading to further 
crystallization, crystal retention and development of stone. Reactive oxygen 
species are produced during the interactions between the oxalate crystals 
and renal cells and are responsible for the various cellular responses. 
Calcium oxalate crystal deposition in the rat kidneys also activates the renin-
angiotensin system. Both oxalate and calcium oxalate crystals selectively 
activate p38 mitogen-activated protein kinase in the exposed tubular cells. 
Extracellular environment changes from one that inhibits crystal nucleation, 
growth, aggregation and retention to that, which promotes these processes 
(Khan et al., 2004). 
 
Although calcium oxalate (CaOx) renal stones are known to grow attached to 
renal papillae, and specifically to regions of papillae that contain Randall's 
plaque (interstitial apatite deposits), the mechanisms of stone overgrowth on 
plaque are not known. Thus, recently Evan et al. (2007) collected biopsy 
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specimens from two stone patients that included an attached stone along 
with its tissue base and studied the ultrastructural features of the attachment 
point using light and transmission electron microscopy, Fourier transform 
infrared spectroscopy (mu-FTIR) and immunohistochemical analysis. He 
found that the epithelium was disrupted at the attachment site. The denuded 
plaque that borders on the urinary space attracts an envelope of ribbon-like 
laminates of crystal and organic matrix arising from urine ions and molecules. 
Into the matrix of this ribbon grow amorphous apatite crystals that merge with 
and give way to the usual small apatite crystals imbedded in stone matrix; 
eventually CaOx crystals admix with apatite and become the predominant 
solid phase. Over time, urine calcium and oxalate ions gradually overgrow on 
the large crystals forming the attached stone. 
 
2.2.3 RISK FACTORS FOR KIDNEY STONE FORMATION 
 
a. Sex and age 
Normal women excrete more citrate and less calcium than normal men, 
perhaps a reason why men form stones more often. Four of every five 
patients with stones are men. In both sexes the peak age of onset is between 
20 and 30 years (NIH Consens statement). In older women and men, greater 
intakes of dietary calcium, potassium and total fluid reduce the risk of kidney 
stone formation, while supplemental calcium, sodium, animal protein and 
sucrose may increase the risk (Curhan et al., 2005, Curhan et al., 1997). 
 
b. Body size and mass 
The association between calcium intake and kidney stone formation varies 
with body size (Taylor et al., 2004). Larger body size may result in increased 
urinary excretion of calcium, oxalate and uric acid, thereby increasing the risk 
for calcium-containing kidney stones. Obesity and weight gain increase the 
risk of kidney stone formation. The magnitude of the increased risk may be 
more in women than in men (Taylor et al., 2005). 
 
c. Hereditary or personal history of renal stone 
There is relatively increased risk in subjects with family history for calculosis 
(Amato et al., 2004). Around half of all people who have previously had a 
kidney stone will develop another one within five years. Genetically inherited 
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disorders account for some stone formation. Low urine pH from hereditary 
causes promotes uric acid stones. Cystine stones occur only in cystinuria, a 
hereditary disorder of amino acid transport. A slightly higher rate of renal 
stone disease emerged in white Caucasians than in Blacks. (Ramello et al., 
2000). 
 
d. Geographic conditions 
Geography plays a part with more stones noted in the southeast, also known 
as the stone belt. Water properties in different localities are different which 
increase the risk of stone formation when contains high amount of minerals. 
The overall probability of forming stones differs in various parts of the world: 
1-5% in Asia, 5-9% in Europe, 13% in North America, 20% in Saudi Arabia. 
The composition of stones and their location in the urinary tract, bladder or 
kidneys may also significantly differ in different countries. Moreover, in the 
same region, the clinical and metabolic patterns of stone disease can change 
over time (Ramello et al., 2000). 
 
e. Life style factors 
Dietary factors play an important role in kidney stone formation and have 
fluctuated markedly over the centuries. Because it appears that peaks of 
stone disease always occur during periods of affluence and stone episodes 
are rare during war and recession, several authors have concluded that 
nephrolithiasis is Mat least in part—a nutritional disease. Another hint that 
nutrition may be an important determinant of stone formation comes from the 
clinical presentation of stone disease.  
 
Two observations highlight the association between dietary factors and stone 
formation. First, the `stone boom', which corresponds to the dramatic 
increase in stone disease incidence in western industrialized nations, after 
World War II, compared to the period during the war when malnutrition was 
the rule. Second, the `stone clinic effect', a phenomenon described by the 
Mayo Clinic years ago to explain the reduction of stone recurrence in 2/3 of 
the patients after basic dietary advice (Hosking et al., 1983). 
 
The role of many nutrients like calcium, oxalate, magnesium, phosphorus, 
sodium, potassium, protein and dietary phylates has been investigated in the 
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last years, because of their known effect upon urinary excretion as either 
promoters or inhibitors of stone formation. 
 
Calcium 
In the past, calcium restriction became a very popular recommend at ion 
based on the high incidence of hypercalciuria (around 50%) (Pak, 1998) in 
calcium stone forming patients, its impact on calcium oxalate and phosphate 
saturation (Coe et al., 1997) and also because of the contribution of calcium 
intake and intestinal calcium hyperabsorption to hypercalciuria. An acute oral 
calcium load test, described in1975 by Pak et al., was reported to clearly 
distinguish between absorptive and renal hypercalciuria. In a previous 
evaluation by Heilberg et al. in 1996, a 24-h urinary calcium excretion, under 
conditions of a mean usual calcium intake of 540 mg/day, was determined in 
patients who previously presented an absorptive or renal response to this 
test and observed that the majority of them, 63 and 78% of each group, 
presented normocalciuria rather than hypercalciuria. Since this apparently 
normal calcium excretion might have resulted from a combination of high 
calcium absorption and low calcium intake, those patients were then 
challenged to a higher calcium intake of 1500 mg/day given as supplement 
for 1 week. Regardless of whether there was a former absorptive or renal-like 
response to the acute load, the higher calcium intake disclosed the presence 
of subpopulations sensitive to calcium intake in previously normocalciuric 
patients. Conversely, most of the hypercalciuric patients when challenged to 
a higher calcium intake did not present a further increase in their urinary 
calcium, showing that under conditions of low calcium intake, as it is the case 
for the Brazilian population (Martini et al., 1993), patients were already 
excreting calcium in excess of their intake, and therefore considered as 
dietary calcium-independent. In addition, as the morning urinary fasting 
calcium/creatinine (Ca:Cr) ratio seemed to be the single parameter which 
would distinguish between renal and absorptive hypercalciuric patients, with 
a cut off value of 0.11, Heilberg et al. repeated this determination in 31 
patients  and found that 87% of them changed their results from values 
higher than 0.11 to lower values. Taken together, these data suggest that 
absorptive and renal hyper calciuria should be considered the same rather 
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than two distinct entities, a hypothesis already raised by Coe et al. in 1982, 
representing two extremes of a continuum behavior resulting from an 
abnormal regulation of 1,25 vitamin D. In a large prospective epidemiological 
study conducted by Curhan et al. in 1993, healthy men with different levels of 
calcium intake were followed-up for 8 years, and a surprising observation 
was made: the lower the calcium intake, the higher the incidence of stone 
formation. High intake of dietary calcium appears to decrease risk for 
symptomatic kidney stones, whereas intake of supplemental calcium may 
increase risk. Because dietary calcium reduces the absorption of oxalate, the 
apparently different effects caused by the type of calcium may be associated 
with the timing of calcium ingestion relative to the amount of oxalate 
consumed. However, other factors present in dairy products (the major 
source of dietary calcium) could be responsible for the decreased risk seen 
with dietary calcium (Curhan et al.,1997). 
 
The association between calcium intake and kidney stone formation varies 
with age. Because age and body size affect the relation between diet and 
kidney stones, dietary recommendations for stone prevention should be 
tailored to the individual patient (Taylor et al., 2004). A hypothesis to explain 
this at first sight contraindicative relationship was that low calcium 
concentrates in the intestinal lumen caused a secondary increase in urinary 
oxalate due to decreased binding of oxalate to calcium within the 
gastrointestinal tract. Nevertheless, Bushinsky et al. in 1994 in an 
experimental model of genetic hypercalciuric rats fed increasing amounts of 
calcium in the diet observed a proportional increase in urinary calcium 
compared to the respective controls, but this was not accompanied by a 
parallel decrease in urinary oxalate. In patients, the effects of increasing 
calcium intake from 500 to 1500 mg/day upon oxalate excretion have been 
evaluated by Nishiura et al. in 1999 and the preliminary results show a 
significant decrease of urinary oxalate in hypercalciuric but not in 
normocalciuric patients. Additional studies are still needed to further clarify 
whether the postulated relationship between colonic oxalate absorption and 
colonic load of calcium is different in hypercalciuric versus normocalciuric 
subjects. Focusing on the bone issue, many investigators addressed the loss 
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of bone mass in hypercalciuric patients (Heilberg et al., 1994; Bataille et al., 
1991; Jaeger et al., 1994; Weisinger, 1996; Zanchetta et al., 1996; 
Pietschmann et al., 1992; Heilberg et al., 1998). 
 
The authors also stressed the role of a low calcium diet in the genesis of 
such loss (Heilberg et al., 1994; Bataille et al., 1991; Jaeger et al., 1994; 
Weisinger, 1996; Zanchetta et al., 1996; Pietschmann et al. 1992; Heilberg et 
al., 1998; Trinchieri et al.1998). 
 
But one has to keep in mind that calcium excretion is not solely affected by 
the intake of calcium, but that of other nutrients as well, such as animal 
protein, sodium, oxalate and potassium (Bataille et al., 1991; Massey et al., 
1993; Massey et al., 1996; Lemann et al., 1991). 
 
Sakhaee et al. in 1993 focused on the fact that calcium citrate 
supplementation does not increase the risk of stone formation in healthy 
postmenopausal women. The co-administered potassium citrate may provide 
additional protection against formation of uric acid and calcium oxalate 
stones. 
 
Regular calcium supplementation does not raise the product of calcium and 
oxalate in urine and the proportion of oxalate to calcium is reduced. 
Increased oral calcium, in association with a reduction of the relative 
proportion absorbed, may be pertinentto the prevention of calcium oxalate 
rich stones (Williams et al., 2001). 
 
In summary, there are many reasons why calcium restriction should be 
avoided in hypercalciuric patients, as listed below. 
(i) There is no clear distinction between absorptive and  hypercalciuria. 
(ii) No prospective studies are available to support the belief that calcium 
restriction leads to a reduction of stone recurrence. 
(iii) Calcium restriction induces secondary hyperoxaluria. 
(iv) It predisposes also to bone loss due to a negative calcium balance. 
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(v) In addition, chronic calcium restriction might upregulate vitamin D 
receptors allowing 1,25 vitamin D to more intensely stimulate both intestinal 
calcium absorption and bone resorption. 
(vi) Other nutrients such as protein, sodium, oxalate and potassium affect 
calcium excretion as well. 
Today more experts advise higher calcium intake. Although still hypothetical, 
this may even have additional advantages (Hess et al., 1998). The 
substitution of meat protein by dairy product-derived protein will provide a 
higher intake of phosphate which co-precipitates with calcium in the intestinal 
lumen so that urinary phosphate does not increase; since calcium and 
magnesium compete for a common reabsorptive mechanism in the loop of 
Henle, increases in urinary calcium excretion are expected to induce an 
increase in urinary magnesium, a known inhibitor of crystal aggregation. 
Nevertheless, one has to consider that the benefits of a high calcium supply 
do not apply to calcium supplements, which usually are not taken with meals, 
hence losing their oxalate chelating properties (Curhan et al., 1997). 
 
Oxalate 
Aside from primary and enteric hyperoxaluria, most cases found in patients 
have `mild hyperoxaluria', defined by levels of urinary oxalate from 40 to 100 
mg/day, with a reported frequency of 12–63% (Borsatti, 1991). 
 
Marangella et al. in 1982 have suggested that `mild hyperoxaluria' might be 
secondary to calcium hyperabsorption. The rational basis for oxalate 
restriction relies on the fact that calcium oxalate is the main component of 
most renal stones, and that there is a lower molar urinary oxalate 
concentration than calcium (Ca:Ox ratio is 5:1). This means that small 
changes in oxalate concentration have much larger effects on CaOx 
crystallization than large changes in calcium concentration. A recent 
experimental study by Bushinsky et al. in 1999 has shown that increases of 
dietary oxalate up to 2% during 18 weeks in hypercalciuric rats produced an 
elevation in oxalate excretion and a fall in urinary calcium excretion, probably 
due to oxalate binding intestinal calcium. In this model, since the higher 
urinary oxalate was offset by lower urinary calcium, the net effect was a 
CHAPTER-2                                                LITERATURE REVIEW 
 Page 18  
decrease of CaOx saturation ratio. These results have raised the issue 
whether it is necessary at all to limit dietary oxalate intake in stone formers. 
In humans, only 10–15% of urinary oxalate is derived from the diet (Hess, 
1996). 
 
Additionally, the ability of oxalate-rich food items to augment oxalate 
excretion depends not only on the oxalate content, but also on its 
bioavailability, its solubility and the form of salt in which it is present. Only 
spinach and rhubarb are considered to be high risk food items, for their high 
amounts of bioavailable oxalate. Peanuts, instant tea, almonds, chocolate 
and pecans are considered as moderate risk food items (Brinkley et al., 
1990). 
 
Finally, the effect of dietary oxalate on urine oxalate critically depends upon 
calcium intake, since decreasing the calcium load in the intestinal lumen will 
increase the concentration of free oxalate anions available for absorption, as 
mentioned above. In healthy subjects, Hess et al. in 1998 have shown that 
the hyperoxaluria caused by a 20-fold increase in oxalate load can be totally 
prevented by a very high calcium intake of about 4 g/day. Accordingly, they 
were then currently investigating whether this also holds true for smaller 
amounts of both nutrients in patients (unpublished data). Preliminary results 
had shown no changes in oxalate or calcium excretion after a 2-foldincrease 
in oxalate intake produced by consumption of one big milk chocolate bar per 
day containing 95 mg of oxalate and 430mg of calcium for 3 days. Marshall 
et al. in 1972 have studied the effects of either oxalate or calcium restriction 
alone, as well as this concomitant restriction in stone forming patients and 
controls. In patients, oxalate restriction did not alter calcium excretion to a 
major extent and produced only a very minor decrease in urinary oxalate. 
CaOx activity was not altered much. On the other hand, a severe calcium 
restriction (down to 250 mg/day) caused an important elevation of urinary 
oxalate only when the supply of dietary oxalate was normal. The combined 
restriction of calcium and oxalate was the only way to prevent such an 
increase in urinary oxalate excretion, leading to an effective decrease of 
CaOx product activity far below the formation product.  Bataille et al. in 1983 
evaluated the probability of stone formation after combined restriction of 
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calcium and oxalate. He observed that the combined restriction was not able 
to decrease the probability of stone formation in dietary-independent 
hypercalciuria patients, in as much as a concomitant increasein oxalate 
excretion was still noted in these patients.  
 
Increasing dietary oxalate led to a decrease in CaOx and CaHPO4 
supersaturation and did not alter the universal stone formation nor the type of 
stones formed studied by Bushinsky et al. recently in 1999. Oxalate intake 
and spinach were not associated with risk of kidney stone formation in 
younger women reported by Taylor et al. most recently in 2007. In summary, 
the idea that a balance between calcium and oxalate intake must be 
maintained during meals is unquestionable. Long-term controlled studies are 
needed, however, to resolve whether one should recommend restriction of 
both items or recommend no restriction at all. 
 
These foods are high in oxalate (greater than 10 mg per serving): (Omoloja 
et al., 2005) 
• Beans in tomato sauce 
• Beer 
• Beets 
• Blackberries 
• Black and red raspberries 
• Blueberries 
• Celery 
• Chard 
• Chocolate 
• Cocoa 
• Coffee powder (Nescafe) 
• Collards 
• Concord grapes 
• Crackers made from soy flour 
• Currants 
• Dandelion greens 
• Eggplant 
• Escarole 
• Fruit cake 
• Fruit salad (canned) 
• Green bell pepper 
• Grits (white corn) 
• Juices containing berries 
• Kale 
• Leeks 
• Lemon and lime peel 
• Nuts (especially peanuts and 
pecans) 
• Okra 
• Ovaltine 
• Parsley 
• Pokeweed 
• Rhubarb 
• Rutabagas 
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• Spinach 
• Strawberries 
• Summer squash 
• Sweet potatoes 
• Tea 
• Tofu 
• Tomato soup 
• Wheat germ 
 
These foods are moderately high in oxalate (2–10mg per serving):             
• Apple 
• Apricots 
• Asparagus 
• Bottled beer (12 oz [360 ml] 
limit/day) 
• Broccoli 
• Carrots 
• Chicken noodle soup (dried) 
• Coffee (8 oz [240 ml]) 
• Cola beverage (12 oz [360 
ml] limit per day) 
• Corn 
• Cornbread 
• Cucumber 
• Lettuce 
• Lima beans 
• Marmalade 
• Oranges 
• Orange juice (4 oz [120 ml]) 
• Parsnips 
• Peaches 
• Pears 
• Peas (canned) 
• Pepper (greater than 1 tsp [2 
grams] per day) 
• Pineapple 
• Plums 
• Prunes 
• Sardines 
• Soy products (most) 
• Sponge cake 
• Tomatoes 
• Tomato juice (4 oz [120 ml]) 
• Turnip 
• Watercress 
 
 
 
 
 
These foods are low in oxalate (0–2 mg per serving); eat as desired: 
• Apple juice 
• Avocado 
• Bacon 
• Bananas 
• Beef (lean) 
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• Bing cherries 
• Brussels sprouts 
• Cabbage 
• Cauliflower 
• Cheese 
• Eggs 
• Grapefruit 
• Green grapes 
• Jellies 
• Lamb (lean) 
• Lemonade or limeaid (without peel) 
• Melons 
• Milk 
• Mushrooms 
• Pork (lean) 
• Poultry 
• Preserves 
• Nectarines 
• Noodles 
• Oatmeal 
• Oils 
• Onions 
 
Magnesium 
Kidney stones have repeatedly been produced in magnesium-deficient 
animals (Hodkinson, 1958). Total serum magnesium and erythrocyte 
magnesium levels may be low in recurrent stone formers (Schmiedl et al., 
1996). Perhaps 5% of stone formers have hypomagnesiuria (Preminger et 
al., 1989) and the urine of over 25% of stone formers has lowered 
magnesium to calcium ratio (Labeeuw et al., 1987). The hypomagnesiuria 
appears to be due to inadequate magnesium intake, as magnesium 
absorption following supplementation appears to be normal (Johansson et 
al., 1980). Magnesium intake decreases and total vitamin C intake seems to 
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increase the risk of symptomatic nephrolithiasis (Taylor et al., 2004). In some 
studies, magnesium has been combined with vitamin B6 with good results 
(Rattan et al., 1994). 
 
Supplementation with magnesium salts may inhibit stone formation, even in 
patients without magnesium deficiency (Johansson et al., 1982). Magnesium 
decreases the urinary saturation of calcium oxalate by combining with urinary 
oxalate to form soluble magnesium oxalate (Goldwasser B et al., 1986) so 
long as it is administered with meals (Lindberg et al., 1990). 
 
Phosphorus 
In stone formers, urinary phosphorus may be elevated, thus creating the risk 
of phosphate deficiency (Schwille et al., 1997). 
 
Hyperphosphaturia appears to correlate with urinary calcium levels (Kitamura 
et al., 1989); in fact, there is evidence that patients with idiopathic 
hypercalciuria excrete excessive phosphate for any given serum calcium 
concentration. Loss of phosphate may increase the activation of 1,25-
dihydroxyvitamin D (Williams et al., 1996). There also appears to be a failure 
of the kidneys to convert orthophosphate to pyrophosphate (Conte et al., 
1989). 
 
Supplementation with orthophosphate reduces urinary calcium (Palmqvist et 
al., 1988) with reduction in calcium oxalate supersaturation and stone 
formation. However, unless baseline phosphate levels are low (Alvarez-
Arroyo et al., 1992), the reduction in stone formation appears to be limited 
(Palmqvist, 1988), especially as compared to other treatments such as alkali 
citrate or magnesium (Tiselius et al., 1990). 
 
 
Protein 
The nutrient that clearly has universal effects on most of the urinary 
parameters involved in stone formation is protein. High protein intake of 
animal origin contributes to hyperuricosuria due to the purine overload, to 
hyperoxaluria due to the higher oxalate synthesis and to hypocitraturia due to 
the higher tubular reabsorption of citrate (Breslau et al., 1988; Holmes et al., 
1993). Additionally, protein-induced hypercalciuria may be caused by higher 
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bone resorption and lower tubular calcium reabsorption to buffer the acid 
load, and also by the elevated filtered load of calcium and by the presence of 
non-reabsorbable calcium sulfate in the tubular lumen (Breslau et al., 1988). 
An acute moderate protein restriction reduces urinary oxalate, phosphate, 
hydroxyproline, calcium and uric acid and increases citrate excretion, as 
recently reported (Giannini et al., 1999). Several authers observed a strong 
correlation between intake of dietary animal protein and nephrolithiasis. 
While it is generally accepted that excess of dietary protein leads urinary 
excretion of lithogenic substances such as calcium and uric acid to rise and 
excretion of citrate to fall, Nguyen et al., suggested in 2001 diet providing 
high amounts of protein derived from meat induces an increased urinary 
oxalate excretion in recurrent calcium stone formers. 
 
Urinary crystallization studies by Breslau et al. in 1988 revealed that the 
animal protein diet, when its electrolyte composition and quantity of protein 
were kept the same as for the vegetarian diet, conferred an increased risk for 
uric acid stones, but, because of opposing factors, not for calcium oxalate or 
calcium phosphate stones. 
 
In men with recurrent calcium oxalate stones and hypercalciuria, restricted 
intake of animal protein and salt, combined with a normal calcium intake, 
provides greater protect ion than the traditional low-calcium diet indicated by 
Loris et al. in 2002. It was suggested that high animal protein and sodium 
intake are contributory factors (Bataille et al., 1991; Jaeger et al., 1994; 
Weisinger, 1996; Zanchetta et al., 1996; Pietschmann et al., 1992). 
 
Studies were carried out on six normal male subjects to determine the short-
term effect of increasing the dietary consumption of animal protein on the 
urinary risk factors for stone-formation, namely, volume, pH, calcium oxalate, 
uric acid and glycosaminoglycans. An increase of 34 g/day of animal protein 
in the diet significantly increased urinary calcium (23%) and oxalate (24%). 
Total urinary nitrogen increased by an average of 368 mmol/day. The 
accompanying increase in dietary purine (11 mmol of purine nitrogen/day) 
caused a 48% increase in the excretion of uric acid. The overall relative 
probability of forming stones, calculated from a combination of the risk 
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factors, was markedly increased (250%) throughout the period of high animal 
protein ingestion (Robertson,  1969). 
 
Potassium 
An epidemiological study has reported that lower the potassium intake, below 
74 mmol/day, the higher the relative risk of stone formation. Such an effect 
can be ascribed to an increase in urinary calcium and a decrease in urinary 
citrate excretion induced by a low potassium intake (Lemann et al., 1991). 
The administration of 60 mmol/d of KHCO3 to healthy adults reduced urinary 
calcium excretion by 0.9 mmol/d and caused calcium balance to become 
equivalently more positive. Other studies showed that90 mmol/d of KHCO3 
reduced both daily and fasting urinary calcium excretion rates, whereas 
deprivation of either KCl or KHCO3,using synthetic diets, was accompanied 
by increased daily and fasting urinary calcium excretion rates. A significant 
inverse relationship between the changes in urinary calcium and the changes 
in urinary potassium was observed. The fall in urinary calcium during 
potassium administration may be related to the natriuretic effects of 
potassium, resulting in ECF-volume contraction or to potassium-induced 
phosphate retention and suppression ofcalcitriol synthesis, or to both 
mechanisms (Lemann et al., 1969). Borsatti, studied in 1991 that a low-
normal potassium intake and a higher sodium chloride intake were observed 
in stone formers when compared to healthy subjects. The overall effect was 
a significantly higher urine Na/K ratio (Martini et al., 1998) increasing the risk 
for stone formation, as previously suggested by Cirillo et al. in 1994. 
 
Sodium 
The effect of sodium chloride (NaCl) intake on increasing calcium excretion is 
well established. Every 100mmol increase in dietary sodium increases 
urinary calcium excretion by 25 mg (Lemann et al., 1979). The adverse 
effects of a high sodium chloride intake and the resultant higher calcium 
excretion have been well documented by many investigators (Massey et al., 
1996; Muldowney et al., 1982; Breslau et al., 1982). 
 
In a previous analysis of our group (Martini et al., 2000) multiple regression 
suggested that a high sodium chloride intake (16 g/day), was the single 
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variable that was predictive of risk of low bone mineral density in 85 patients 
after adjustments for age, weight, body mass index, duration of stone 
disease, calcium and protein intakes and urinary calcium citrate and uric 
acid. Finally, a high sodium chloride intake is expected to lower citrate 
excretion as well (Sakhaee et al., 1993). 
 
Fluids 
A high fluid intake is a very important goal to reduce urine supersaturation. A 
very well conducted 5-year randomized, prospective study involving first 
stone episode patients has shown lower rates of recurrence (12%) in those 
with a higher intake of water compared to those without (27%). It should be 
emphasized that patients received no drug therapy and were not submitted 
to any dietary change so that the effect was exclusively explained by the 
selective increase in urinary volume (Borghi et al., 1996). 
 
Fink et al. indicated high fluid intake decreased risk of recurrent 
nephrolithiasis. Reduced soft drink intake lowered risk in patients with high 
baseline soft drink consumption. 
 
To what extent the hardness and mineral composition of water affect stone 
risk remains controversial (Agreste et al., 1999; Caudarella et al., 1998). As 
the calcium content of drinking water increases, calcium excretion increases, 
but oxalate excretion falls (Caudarella et al., 1998; Marangella et al., 1996). 
Water with a large amount of bicarbonate may increase citrate excretion 
(Caudarella et al., 1998) and magnesium content may favourably alter citrate 
and magnesium excretion (Rodgers et al., 1997). Based on these findings, 
there is still no definite evidence that hard water, rich in calcium and 
magnesium, is more lithogenic than soft water. A very recent epidemiological 
study based onfood-frequency questionnaires has examined the effects of 
particular beverages on the risk of symptomatic kidney stones in women 
(Curhan et al., 1998). Consumption of caffeinated and decaffeinated coffee 
was associated with a reduction of risk of 8–10%, while wine decreased the 
risk by 59%. Conversely, grapefruit juice ingestion was associated with a 
44% increased risk for stone formation. The authors speculated that the 
protective effects of coffee, tea and wine were caused by urinary dilution, 
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determined by the ability of caffeine and alcohol to inhibit antidiuretic 
hormone. Therefore, the decreased risk for decaffeinated coffee might have 
been conferred by another mechanism. The adverse effects of grapefruit 
juice remained unexplained, since other citrus juices, such as orange and 
lemon, apparently prevent (Seltzer et al., 1996; Wabner et al., 1993) and at 
least fail to stimulate stone formation because of their high citrate content. In 
summary, these results must still be interpreted with caution until adequate 
long-term randomized trials of dietary interventions are performed. Advice to 
follow a low animal protein, high fiber, high fluid diet has no advantage over 
advice to increase fluid intake alone reported by Hiatt et al. in 1996. 
 
Vitamin C 
The effect of large doses of vitamin C in increasing urinary oxalate excretion 
is controversial (Hughes et al., 1981; Wandzilak et al., 1994). At least in partit 
may be a methodological artifact accounted for by the conversion of vitamin 
C to oxalate during the analytical procedure (Wandzilak et al., 1994).In a 
recent large epidemiological study, it was reported that the intake of vitamin 
C was not associated with risk of kidney stones in women (Curhan et al., 
1999). 
 
Phylate  
Recently, dietary phylate has been suggested to play a role in stone 
formation. (Grasses et al., 2000, 1998) Phylate (myoinositol hexaphosphate) 
bind stightly to doubly charged cations such as calcium. Binding of calcium in 
the gastrointestinal tract may increase the absorption of dietary oxalate and 
thereby increase the risk of calcium oxalate stone formation (Lemann, 1993). 
 However, phylate also is a strong inhibitor of calcium oxalate crystal 
formation in vitro (Grases et al., 1998).  Recent evidence (Grases et al., 
2000) suggests that ingested dietary phylate is absorbed and excreted in the 
urine. Thus, a higher intake of dietary phylate could reduce the risk of stone 
formation. 
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Fatty / High Caloric food 
The increased prevalence of stones is linked to weight gain and obesity, 
making weight loss a possible therapy to prevent stones. Randomized trials 
show that diets consisting of low-fat content or low-caloric content cause 
modest weight loss and might be effective in reducing stone formation. 
(Goldfarb, 2009) 
 
Fluoride 
Singh suggested in 2001 that fluoride in vivo may behave as a mild promoter 
of urinary stone formation by excretion of insoluble calcium fluoride, 
increasing oxalate excretion and mildly increasing the oxidative burden. 
 
Therefore, the influence of diet on renal stone disease seems to be much 
more complex than thought in the past because multiple interactions take 
place between the different nutrients and thus variably influence urinary 
parameters. 
 
f. Associated diseases 
Bowel disease: Several Bowel diseases increase calcium phosphate 
supersaturation. The propensity for renal stone formation is increased in 
patients with Crohn's disease due to increased urinary oxalate and 
decreased urinary magnesium and citrate concentrations (Bohles et al., 
1988).  
 
Urinary tract diseases: Renal tubular acidosis increases calcium phosphate 
supersaturation. Struvite supersaturation occurs only when urine is infected 
with microorganisms that possess urease and are rightly called "infection" 
stones. 
 
Diabetes mellitus: It is a risk factor for the development of kidney stones. 
However, additional studies are needed to determine if the increased risk of 
Diabetes Mellitus in stone formers is due to subclinical insulin resistance 
(Taylor et al., 2005). 
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Surgeries: People having a disease of the small intestine or a small 
intestinal bypass or people having only one kidney or an abnormally shaped 
kidney are more prone to have renal stones. 
 
Spinal cord injury: Recurrent urinary tract infections, indwelling catheters, 
vesicoureteral reflux, and immobilization hypercalcuria are a few of the major 
risk factors for the development of urolithiasis among spinal cord injury 
patients. Retrograde endourologic techniques are often not possible to 
address stone disease due to lower extremity contractures, spinal curvature 
and pelvic tilt. Early identification and treatment of urolithiasis in spinal cord 
injury patients can so aid in preserving renal function and minimizing 
associated complications (Ost et al., 2006). 
 
Others: People being regularly dehydrated or those having very poor 
mobility (e.g., being confined to bed) have more chances to suffer from 
nephrolithiasis. A high frequency of stone formation among hypertensive 
patients has been reported (Ramello et al., 2000). Whereas Cappuccio et al., 
1990 has already proved that an independent clinical association exists 
between the occurrence of urolithiasis and hypertension and the increased 
urinary calcium excretion commonly detected in hypertension may be the 
pathogenetic link. 
 
g. Medications: 
Certain medicines such as diuretics (water tablets), antacids and thyroid 
medications increase calcium concentration in urine. Certain drugs like 
sulphamethoxazole, phenytoin, trimethoprim, indinavir, etc can form stones. 
Medications such as antacids that alter urine pH may increase susceptibility 
for kidney stones.  
 
2.2.4 FACTORS AFFECTING KIDNEY STONE FORMATION 
 
Hypercalciuria 
It can result from many diseases. Hyperparathyroidism, renal tubular 
acidosis, sarcoidosis, vitamin D intoxication and several other causes can 
lead to hypercalciuria. Hypercalciuria results in oxalate stones. A number of 
endocrine, renal and bone diseases can cause hypercalciuria. Urinary 
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calcium excretion is substantially influenced by dietary intakes of calcium, 
sodium, protein, carbohydrates, alcohol and potassium: a poorly balanced 
diet can result in hypercalciuria. Mutations affecting the calcium-sensing 
receptor (CaSR) have been identified in other forms of hypercalciuria. 
Idiopathic hypercalciuria can also be observed because of increased 
intestinal absorption of calcium, defective reabsorption of calcium by the 
renal tubule or increased bone resorption. Overexpression of the vitamin D 
receptor (VDR) and deficiencies in renal tubule enzymes may also be 
involved (Maurice et al., 2000). 
 
Hyperoxaluria 
It may be due to overproduction, from hereditary disorders of metabolism or 
be acquired from intestinal disease or diet. It occurs in patients with short 
bowel syndrome or malabsorption. Acquired hyperoxaluria is common in 
children with a variety of intestinal disorder (Voghenzi et al., 1992). 
 
Hyperuricosuria 
Hyperuricosuria, from dietary purine excess or from endogenous 
overproduction, and low urine pH, can promote stones that are pure uric 
acid, or mixed calcium oxalate--uric acid stones; hyperuricosuria can promote 
seemingly pure calcium oxalate stones. Other heterogeneous nucleators 
may be urine proteins, Tamm- Horsfall protein, the urothelial surface itself 
and other crystals. Serum uric acid level at or below 6 mg/dl is often the goal 
of the drug's use in patients with gout or hyperuricemia.  
 
Hypocitrauria 
Citrate is an important inhibitor of urolithiasis, which forms soluble complexes 
with calcium and inhibits precipitation of calcium oxalate and phosphate, and 
growth of their crystals. Most of the time hypocitraturia is idiopathic but it can 
be associated with small bowel malabsorption, chronic diahorria, diets high in 
protein and salt, low levels of blood potassium often associated with thiazide 
diuretics and such other factors (Francosis et al., 1986). Patients with 
idiopathic renal tubular acidosis (iRTA) tended to have less urinary citrate 
and higher calcium/citrate ratio than did idiopathic stone formers and was 
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common among recurrent calcium stone formers. Hypocitraturia might result 
from low potassium and low alkaline intake (Stitchantrakul et al., 2007). 
 
Hypomagnesuria: 
Many experimental studies have suggested that administration of 
magnesium salts prevents stone disease. Urinary magnesium is known as 
the inhibitor of calcium oxalate stone formation (Yuji et al., 2004). Thus, 
magnesium deficiency may lead to increased chances of urolithiasis. 
Elevated levels of arachidonic acid in cell membranes may promote the 
hypercalciuria and hyperoxaluria that are characteristic of idiopathic calcium 
nephrolithiasis. The intake of n-3 fatty acids, such as eicosapentaenoic acid 
(EPA) and decosahexaenoic acid (DHA), may decrease the arachidonic acid 
content of cell membranes and reduce urinary excretion of calcium and 
oxalate. It has been proposed that greater intake of EPA and DHA (through 
dietary sources or fish oil supplementation) may reduce the risk for kidney 
stone formation. However, after studies now it has been proved that fatty 
acid intake is not consistently associated with the development of kidney 
stones. Greater levels of arachidonic and linoleic acid intake do not increase 
the risk for developing a kidney stone, and greater intake of n-3 fatty acids 
does not reduce the risk (Taylor et al., 2005). 
 
Uromodulin may promote aggregation of calcium oxalate crystals (Carvalho 
et al., 2002). 
Hyaluronic acid (HA), an extremely large glycosaminoglycan is a major 
constituent of the extracellular matrix in the renal medullary interstitium and 
the pericellular matrix of mitogen/stress-activated renal tubular cells. HA is an 
excellent crystal-binding molecule because of its size, negative ionic charge 
and ability to form hydrated gel-like matrices. Crystal binding to HA leads to 
crystal retention in the renal tubules (nephrocalcinosis) and to the formation 
of calcified plaques in the renal interstitium (Randall's plaques) (Verkoelen, 
2006). 
 
The 29 kDa protein isolated from uric acid rich stone matrix and urine are 
one and the same, thereby insinuating that 29 kDa protein might play a major 
role in epitaxial deposition of calcium oxalate over uric acid core, 
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consequently favoring the lithogenic events like uric acid and calcium oxalate 
nucleation, aggregation and retention (Srinivasan et al., 2006). 
 
Tamm-Horsfall protein (THP) may act on nucleation and inhibit crystal 
aggregation (Carvalho et al., 2002). But structurally abnormal THPs from 
recurrent calcium stone formers may promote crystal aggregation. Therefore, 
increased urinary excretion of abnormal THP is of relevance in 
nephrolithiasis. Severely recurrent calcium stone formers with a positive 
family history excrete more THP than healthy controls. Such increasingly 
aggregated THP molecules predispose to exaggerated calcium oxalate 
crystal aggregation, an important prerequisite for urinary stone formation 
(Jaggi et al., 2007). THP has a dual role in modifying crystal aggregation: at 
high pH and low ionic strength (IS) THP is a powerful crystal aggregation 
inhibitor. Upon lowering pH and raising IS, THP viscosity increases, leading 
to reduced crystal aggregation inhibition. In the presence of additional 
calcium ions, some THPs even become strong promoters of crystal 
aggregation. This phenomenon seems to be more pronounced in THPs 
isolated from recurrent calcium stone formers whose proteins exhibit an 
abnormally high tendency of polymerization (Hess, 1992). 
 
Citrate appears to be the main determinant of CaOx crystallization rates and 
crystal morphology in the presence of normal Tamm-Horsfall protein (nTHP) 
as well as abnormal stone former Tamm-Horsfall protein (SF-THP). Its 
effects appear to predominate over those of THP, since even promontory SF-
THP is turned into a crystallization inhibitor in the presence of citrate. This re-
emphasizes at a morphological level what has been concluded from 
functional as well from clinical studies, namely that citrate is needed in urine 
at equimolar concentrations to calcium in order to prevent the formation of 
large crystal aggregates in presence of abnormal THP (Hess et al., 2000).  
 
Nephrocalcin (NC) is an inhibitor of calcium oxalate monohydrate (COM) 
crystal aggregation in normal urine (Hess et al., 1989). The 14 kD 
(kilodalton), Gla-containing glycoprotein NC also strongly inhibits crystal 
aggregation. However, NC isolated from urines of recurrent CaOx stone 
formers and from CaOx renal stones are 10 times less inhibitory. Both are 
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structurally abnormal in that they lack Gla and are less amphophilic (Hess, 
1991). 
 
Supersaturation with respect to calcium salts (oxalate and phosphate) is the 
driving force leading to crystalluria and nephrolithiasis. High-molecular weight 
urinary inhibitors are recently described molecules capable of altering the 
process of kidney stone formation. By inhibition of crystal nucleation, growth 
and aggregation and by inhibition of crystal interaction with tubular cells, 
these proteins efficiently prevent stone formation and retention in the urinary 
tract. But in spite of considerable efforts, characterization of these proteins is 
still under way. Besides the pathophysiology of risk factors for calcium salts 
supersaturation such as idiopathic hypercalciuria or hyperoxaluria, the renal 
involvement of protein inhibitors is the most exciting field in the 
comprehensive approach of nephrolithiasis, a disease that affects up to 10% 
of people in Western countries (Dussol et al., 1998).  
Recent studies have identified increasing numbers of macromolecular 
inhibitors such as glycosaminoglycans, bikunin, osteopontin and urinary 
prothrombin F1 (PTF1). These appear to be more important than low- 
molecular inhibitors like citrate (Kohjimoto et al., 2004). Nishio et al., 2000 
reported that osteopontin strongly inhibited the crystal growth of CaOx at 
physiological concentration of 3 mg/L in urine.  α2-HS-glycoprotein and PTF1 
are also selectively associated with calcium phosphate crystals generated in 
normal adult urine. PTF1 and osteopontin strongly inhibit CaOx 
crystallization. Glycosaminoglycans can stimulate the synthesis of glomerular 
basement membrane (GBM) protein by glomerular cells and correct 
biochemical alterations of the GBM (Pieroni et al., 1995). The involvement of 
GAGs in urolithiasis has been extensively evaluated over the last 30 years, 
but their role as inhibitors of crystallization and/or nucleation of calcium 
oxalate remains controversial (Freitas et al., 2002). Surprisingly, untreated 
lithiatic animals had a significantly higher urinary excretion of GAGs in a 
study by Kohjimoto et al., 2004. It suggested dissociation between the 
presence of these macromolecules in the urine and their potential inhibitory 
effect on calculus growth, as higher levels of GAGs were associated with 
larger calculi. In addition, the response of urothelium to irritation caused by 
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the larger amount of crystalline material in the bladder could be responsible 
for the increased urinary excretion of GAGs, as they are integral components 
of the urothelium (Hurst et al., 1994; Freitas et al., 2002) and have an 
important role in the urothelial defence against insults, including bacterial and 
carcinogenic (Akcay et al., 1999; Freitas et al., 2002) Thus, the increased 
level of urinary GAGs in untreated CaOx animals, as a consequence of 
stones, should be considered.  
 
The exogenous administration of progressive doses of chondroitin sulphate 
is reported to be associated with a progressive increase in calculus size, 
followed by a proportional increase in the content of chondroitin sulphate 
inside the calculi (Michelacci et al., 1992, Freitas et al., 2002). Thus, it was 
revealed that in vivo chondroitin sulphate promotes the growth of pre-existing 
crystal by its adsorption to the growth sites of CaOx crystals. The deposition 
of these polyanionic molecules in the calculus would increase the 
electrostatic negative force attracting cations, particularly calcium, and 
promoting crystal growth.  
Angiotensin II receptor blockers eg. candesartan can inhibit superfluously 
induced osteopontin in the whole kidney by ethylene glycol and also 
decrease crystal formation (Hatanaka et al., 2005). Hyperoxaluria-induced 
peroxidative injury induces individual calcium oxalate crystal attachment in 
the renal tubules. Whereas excess vitamin E completely prevents calcium 
oxalate deposition, by preventing peroxidative injury and restoring renal 
tissue antioxidants and glutathione redox balance. Therefore, vitamin E 
therapy might provide protection against the deposition of calcium oxalate 
stones in the kidney of humans (Thamilselvan et al., 2005). The beneficial 
effect of vitamin E in reducing CaOx accumulation is due to attenuation of 
tubular cell death and enhancement of the defensive roles of THP (Huang et 
al., 2006).  
An analysis of calcium oxalate crystals in urine showed that the dehydrate 
form was present in healthy subjects and stone formers, whereas the 
monohydrate, which is thermodynamically more stable and constitutes the 
core of most calcium oxalate stones, was present in stone formers only. 
Nucleation by albumin apparently led exclusively to the formation of calcium 
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oxalate dihydrate crystals, whereas calcium oxalate monohydrate crystals 
were formed in the absence of albumin. This promotion by albumin of 
calcium oxalate crystallization with specific formation of the dihydrate form 
might be protective, because with rapid nucleation of small crystals, the 
saturation levels fall; thus, larger crystal formation and aggregation with 
subsequent stone formation may be prevented. It is so believed that albumin 
may be an important factor of urine stability (Cerini et al., 1999). 
 
2.2.5 TYPES OF KIDNEY STONES 
Kidney stones are made of different types of crystals. Most are (1) calcium 
stones viz., calcium oxalate, calcium phosphate or a combination of calcium 
oxalate and calcium phosphate, (2) magnesium ammonium phosphate, also 
known as struvite or infection stones, (3) uric acid, (4) cystine, and (5) 
miscellaneous types such as occur with drug metabolites. 
 
a. Calcium stones: 
 
 
 
 
 
 
 
Calcium oxalate develops in acid urine. Calcium phosphate develops in 
alkaline urine (pH greater than 7.2). Calcium phosphate stones are also 
associated with urinary tract infection, Renal Tubular Acidosis (RTA) and 
hyperparathyroidism.  
 
Hypercalciuria or increased calcium in the urine may lead to calcium stone 
formation. Often times the blood calcium level is normal even though there is 
elevated calcium in the urine. This may be the result of intestinal 
hyperabsorption of calcium. Renal leak hypercalciuria occurs when there is 
impaired reabsorption of calcium in the kidney, leading to hypercalciuria even 
in a fasting state with no intake of calcium. Resorptive hypercalciuria, which 
is seen in hyperparathyroidism, is characterized by increased bone 
Calcium oxalate & Calcium phosphate stones 
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breakdown and increase in serum calcium level (Maurice et al., 2000). Oddly 
enough, calcium stones may develop in patients who excrete too much uric 
acid (hyperuricosuria). When urine is less than pH 5.5, uric acid crystals 
develop and calcium crystals then begin layering around this crystal to form a 
calcium oxalate stone.  
 
Oxalate forms an insoluble complex with calcium to develop calcium oxalate 
stone. High levels of oxalate in the urine, or hyperoxaluria, is even more 
important to stone formation than high levels of calcium or hypercalciuria. 
Excessive intake of food and drink containing oxalate leads to calcium 
oxalate stones. Also, excessive intake of Vitamin C which is metabolized to 
oxalate may lead to hyperoxaluria and an increase in stone formation. 
Enteric hyperoxaluria is seen in inflammatory bowel disease, bowel resection 
and small bowel bypass procedures. With these conditions there is an 
increase in bile salt and fatty acids that combine with calcium leading to 
increased oxalate available for absorption. With increased intestinal 
absorption of oxalate, there is an increase in urinary oxalate leading to 
formation of calcium oxalate stones. These patients also have low urinary 
citrate and magnesium as a result of chronic metabolic acidosis due to 
chronic diarrhea. All these factors lead to calcium oxalate stone formation. 
 
b. Uric acid stones: 
Uric acid is an end product of purine metabolism. It’s the 
same crystal that causes gout, an arthritic condition. 
Foods high in purines are red meat, fish and chicken. 
The solubility of uric acid depends on the acidity or 
alkalinity of the urine. In acid urine, pH less than 5.5, uric 
acid crystals precipitate  leading to stone formation. If 
urine is alkaline, uric acid remains soluble and doesn’t 
precipitate out. Knowledge of this fact is the basis of the medical treatment of 
uric acid stones. Hyperuricosuria develops in chronic diarrhea, high purine 
intake, and is associated with tumor lysis after chemotherapy or radiation. 
 
 
 
Uric acid stones 
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c. Struvite stones: 
These stones are also call triple phosphate, struvite or 
infection stones. These stones develop when the urine 
pH is higher than 7.2 and ammonia is present in the 
urine. Bacteria that produce urease act on the urea 
present in urine to form ammonia, bicarbonate and 
carbonate ion. The most common bacteria associated 
with struvite stones is proteus, but other bacteria such as Staphylococcal 
aureus, Klebsiella pneumoniae and pseudamonas may also be implicated. 
Since females are more susceptible to urinary tract infection, struvite stones 
occur more often in females than males with a ratio of 2:1.  
 
d. Cystine stones: 
Cystinuria is an autosomal recessive disorder that 
causes impaired renal tubular reabsorption of cystine, 
ornithine, lysine and arginine. This leads to increased 
urinary excretion of these compounds, but the only one 
that forms stonesis the cystine. 
 
 
 
e. Miscellaneous stones: 
Crixivan stones: One of the most common protease 
inhibitors used to treat HIV disease is crixivan or 
indinavir sulfate. Urinary stones have been associated 
with the use of crixivan. Other type of stones can be of 
sulphamethoxazole, guaphenesin, aminophylline, 
ciprofloxacin, triamterene, phenytoin, oxypurinol, etc.  
 
 
2.2.6 SYMPTOMS (Portis et al., 2001) 
Many kidney stones don't move and are too small to cause any symptoms. 
However, if a kidney stone causes a blockage, or moves into the ureter, it 
may cause some of the following symptoms:  
• severe pain or aching in the back on one or both sides 
Struvite stone 
Cystine stone 
Crixivan stone 
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• sudden spasms of excruciating pain (renal or uteric colic); this usually 
starts in the back below the ribs, before radiating around the  abdomen and 
sometimes to the groin and genitalia  
• bloody, cloudy or smelly urine 
• feeling of being sick 
• a frequent urge to urinate or a burning sensation during urination 
• fever and chills, nausea and vomiting 
 
These can also be symptoms of a urinary tract infection or cystitis, which is 
much more common than kidney stones in young women. Kidney stones are 
usually passed out of the body within 48 hours, but attacks can sometimes 
last for over 30 days. 
 
 
2.2.7 DIAGNOSIS 
Doctors can usually diagnose kidney stones by asking about symptoms and 
examining patient. Further tests may be done to confirm the diagnosis and to 
reveal the size, location and type of stone. These include: 
 
Blood tests – These are done to identify excess amounts of certain 
chemicals related to the formation of stones and to check the presence of 
infection by blood cell counts. 
 
Urine analysis – It helps to look for signs of infection and estimation of 
values of various contributing factors viz. oxalates, calcium, cystine, citrates, 
magnesium, phosphates, etc. 
Taking an X-ray image - Stones that contain calcium are usually seen as 
white spots on X-ray images. 
 
An intravenous urogram (IVU) - This involves an injection of a special dye 
that shows up the whole urinary system on X-ray images, revealing stones 
that can't usually be seen. Traditional intravenous pyelography is no longer 
the primary method of investigation in patients with renal colic. If the patient 
has a history of previous attacks of renal colic and stone disease the 
recommended diagnostic approach is to start with plain abdominal 
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radiography and ultrasonography together with Doppler ultrasonography 
(Shokeir, 2002). 
 
Abdominal Ultrasonography 
Abdominal ultrasonography has limited use in the diagnosis and 
management of urolithiasis. Although ultrasonography is readily available, 
quickly performed and sensitive to renal calculi, it is virtually blind to ureteral 
stones (sensitivity: 19 percent), which are far more likely to be symptomatic 
than renal calculi (Yilmaz et al., 1998). 
 
Plain Film Radiography 
Less radiopaque calculi, such as pure uric acid stones and stones composed 
mainly of cystine or magnesium ammonium phosphate, may be difficult, if not 
impossible, to detect on plain-film radiographs. Although 90 percent of 
urinary calculi have historically been considered to be radiopaque, the 
sensitivity and specificity of KUB radiography alone remain poor (sensitivity: 
45 to 59 percent; specificity: 71 to 77 percent) (Levine et al., 1997).  
 
Non-contrast helical computerized tomography - It produces pictures 
from a series of X-ray images taken at different angles - it is sometimes used 
to diagnose kidney stones and is thought to be the most accurate diagnostic 
test. It has become the first-line investigation in a number of centers 
(Masarani et al., 2007). This imaging modality is fast and accurate and it 
readily identifies all stone types in all locations. Its sensitivity (95 to 100 
percent) and specificity (94 to 96 percent) suggest that it may definitively 
exclude stones in patients with abdominal pain (Chen et al., 1999; Vieweg et 
al., 1998; Dalrymple et al., 1998; Boulay et al., 1999). 
 
 
2.2.8 PREVENTION 
More fluid i.e. at least three liters every 24 hours or enough to make urine 
clear rather than a yellow color, helps in preventing any type of kidney stone. 
 
A diet low in protein, nitrogen and sodium, avoiding excess Vitamin C, 
especially Vitamin C supplements, restriction of oxalate-rich foods and 
maintenance of an adequate intake of dietary calcium can help in prevention 
of kidney stones. Though caffeine does acutely increase urinary calcium 
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excretion, several independent epidemiologic studies have shown that coffee 
intake overall is protective for stones. 
 
Measurements of food oxalate content have been difficult and issues remain 
about the proportion of oxalate that is bio-available, versus a proportion that 
is not absorbed by the intestine. Oxalate-rich foods such as chocolate, 
coffee, cola, nuts, strawberries, white bran tea, tomatoes, rhubarb, cooked 
spinach, asparagus, etc are usually restricted to some degree, particularly in 
patients with high urinary oxalate levels, but no randomized controlled trial of 
oxalate restriction was performed to test that hypothesis (NIH Publication 
No.05– 2495, 2004). But recently, Taylor et al., 2007 proved that oxalate 
intake and spinach were not associated with risk in younger women. On the 
contrary, Khan et al., 2007 proved that dietary sources of oxalate can induce 
hyperoxaluria and crystal deposition in the kidneys with associated 
degradation in renal biology. Eliminating oxalate from the diet decreases not 
only urinary oxalate, but also calcium oxalate crystal deposits in the kidneys 
and improves their function. Though the Spirulina diet alone did not induce 
any features relating to stone forming condition suggesting that free radical 
release might have been suppressed due to enrichment of dietary 
antioxidants and vitamins. However, it has been demonstrated that during 
hyperoxaluric conditions the Spirulina diet must possibly be avoided and can 
be considered in normal subjects checked for family history of renal stone 
deposition (Faroog et al., 2005).  
 
Reducing the amount of calcium in diet lowers the risk of developing calcium 
stones. However, research has shown that a diet containing normal or even 
increased amounts of calcium containing food (such as dairy products or 
green leafed vegetables) may be more helpful. High intake of dietary calcium 
appears to decrease risk for symptomatic kidney stones, whereas there is 
equivocal evidence that calcium supplements increase the risk of stone 
formation, though calcium citrate appears to carry the lowest, if any, risk. 
Because dietary calcium reduces the absorption of oxalate, the apparently 
different effects caused by the type of calcium may be associated with the 
timing of calcium ingestion relative to the amount of oxalate consumed. 
However, other factors present in dairy products (the major source of dietary 
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calcium) could be responsible for the decreased risk seen with dietary 
calcium (Curhan et al., 1997). It has been speculated that calcium 
supplement in subjects with low oxalate intake might increase the risk of 
calcium stone formation due to an increase in calcium absorption without a 
significant reduction in oxalate absorption. Taking calcium supplements 
resulted in a reduction in urinary oxalates and an elevation in urinary citrates. 
Both alterations in urinary constituents counterbalanced the elevation in 
urinary calcium which resulted from the calcium supplements (Stitchantrakul 
et al., 2004). 
 
Dietary phylate may be a new, important, and safe addition to our options for 
stone prevention (Curhan et al., 2005). L-Arg supplementation may decrease 
free radicals and tubulary membrane injury in nephrocalcinosis due to 
infiltrating leukocytes and decreased antioxidant enzyme activities as proved 
in rats fed with EG diet (Ozturk et al., 2006). L-Arg act as a potent antilithic 
agent, by increasing the level of citrate in the hyperoxaluria-induced rats and 
decreasing calcium oxalate binding to the THP. L-Arg also effectively 
prevents the deposition of calcium oxalate crystals by curtailing the renal 
epithelial damage and protein oxidation as evidenced by the normal activities 
of urinary marker enzymes in l-arg supplemented hyperoxaluric rats 
(Pragasam et al., 2005). 
 
Dietary salt intake has long been known to contribute increased calcium loss 
in the urine in both normal subjects and in those with hypercalciuria 
(Kleeman et al., 1964; Phillips et al., 1967; Muldowney et al., 1982). A study 
of normal subjects found that increasing dietary salt from 50 to 250 mmol/day 
increased urinary calcium from 2.73 to 3.93 mmol/day or 44%. This increase 
in salt intake also significantly reduced urinary citrate from 3.14 to 2.52 
mmol/day or about 20%. As a result of this increase in calcium and decrease 
in citrate the tendency for calcium phosphate, uric acid and calcium oxalate 
to crystallize all increased significantly (Sakhaee et al., 1993). Decreased 
intake of meat, fish and poultry like protein rich food can avoid uric acid 
stones. Maintaining hygienic conditions and keeping urine free of the bacteria 
can help prevent struvite stones. 
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Potassium citrate is also used in kidney stone prevention. This is available in 
tablet and liquid formulation. The medication increases urinary pH (makes it 
more alkaline), as well as increases the urinary citrate level, which helps 
reduce calcium oxalate crystal aggregation. Optimal 24 hour urine levels of 
citrate are thought to be over 320 mg/liter of urine or over 600 mg per day. 
There are urinary dipsticks available that allow patients to monitor and 
measure urinary pH so patients can optimize their urinary citrate level. For 
those patients interested in optimizing their kidney stone prevention options, 
it's essential to have a 24 hour urine test performed. This should be done 
with the patient on his or her regular diet and activities. The results can then 
be analyzed for abnormalities and appropriate treatment given. Though not a 
"cure", ease can sometimes be found during "mild" pain by walking (if 
possible), preferably in cold air. Some pain relief may also be derived by 
soaking in a hot tub of water.  
 
2.2.9 TREATMENT  
Knowing the composition of the calculus is of importance for a more 
complete evaluation of the metabolic study. The nature of the calculus in fact 
helps the physician to find a convenient metaphylaxis consisting of both 
sanitary and therapeutic measures. Study of the composition of urinary 
stones remains one of the most interesting aspects of the lithiasic pathology 
today (Saita et al., 2007). X-ray analysis was found to exceed X-ray 
diffraction and infrared spectroscopy in its sensitivity for the identification of 
stone components several fold. This was largely due to the inability of the 
latter methods to detect apatite in more than half of the apatite containing 
stones. The findings in X-ray analysis had the best correlation with chemical 
analysis, which was applied mainly to the detection of apatite (Kim et 
al.,1985). Initially, conventional radiography using X-ray imaging was used to 
know stone composition (Oehlschlager et al., 2003). Presently 
crystallographic examination constitutes one of the most precise and less 
expensive methodologies to identify the nature of the concretion. This 
method also allows the urologist to catalogue the typology of the lithiasis 
during endoscopy (Saita et al., 2007). Sequential changes of the 
compositions of recurrent calcium calculi are highly likely to occur with time in 
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individual recurrent calcium stone formers with calcium oxalate monohydrate 
found to be a most common component of the studied recurrent calcium 
stones.  
 
Treatment depends on the type and cause of the stone. The kidney stone 
can be collected by passing urine through filter paper or a tea strainer. The 
stone can then be analyzed to find out what type it is to help guide treatment. 
Simple trigonometry on Computed Tomography of the patients with complex 
stones could help endourologists in planning renal access. It increases the 
stone-free rate up to 92.6% without any chest-related complications (Bilen et 
al., 2007). Patient may be prescribed paracetamol or codeine to reduce the 
pain. Supplementation with magnesium, a smooth muscle relaxant, can help 
reduce pain and facilitate stone passing. However, if there is an infection, a 
blockage, or a risk of kidney damage, patient will receive treatment to 
remove stone. Infections can be treated with antibiotics. During recent 
decades, pharmacologic intervention has become more effective in stone 
disease: drugs can control the pain of renal colic, interfere at various levels in 
lithogenesis, and contribute to the expulsion of stones (Micali et al., 2007). 
 
A. NONPHARMACOLOGIC TREATMENT 
Patients with calcium lithiasis should be advised to consume a diet with a 
normal calcium intake (1000–1200 mg/day) with a fluid intake sufficient to 
result in the passage of 2 L of urine daily to reduce the risk of subsequent 
calcium stones (Kairaitis, 2007). Alternative treatments for kidney stones 
include the use of herbal medicine, homeopathy, acupuncture, acupressure, 
hypnosis, or guided imagery to relieve pain. Dietary changes can be made to 
reduce the risk of future stone formation and to facilitate the resorption of 
existing stones. 
 
B. PHARMACOLOGICAL TREATMENT 
 
a. Drugs: 
• Thiazide diuretics have a role in the prevention of further calcium 
stones in patients with proven stone recurrence. The risk of potential 
side-effects with long-term thiazide treatment should be balanced 
against the severity of stone disease in individual patients.  
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• Allopurinol can be used for the prevention of recurrent calcium lithiasis 
in the presence of either hyperuricaemia or hyperuricosuria. 
• Theoretical support for the use of potassium and magnesium salts is 
observed since dietary intake of both is inversely related to the risk of de 
novo calcium stone formation. 
• Citrate therapy has been proven to be effective at preventing further 
stone formation in patients with recurrent calcium stones. The frequency 
of side-effects (including nausea, diahorrea, bloating and rash) 
associated with citrate and the need for long-term treatment is likely to 
limit the population of patients eligible for this treatment.  
• Oral magnesium or phosphate therapy is beneficial in the prevention 
of calcium stone recurrence. While antibiotics are prescribed to keep 
microbes away causing struvite stones (Lukas, 2007). 
• Depending on the stone formation disease, vitamin B-6 and 
orthophosphate supplements may be helpful, although these 
treatments are generally reserved for those with Hyperoxaluria. 
• Cellulose supplements have also shown potential for reducing kidney 
stones caused by hypercalciuria (excessive urinary calcium) although 
today other means are generally used since cellulose therapy is 
associated with significant side effects.  
• A drug called acetohydroxamic acid (AHA) is used with long-term 
antibiotic drugs to prevent the infection that leads to stone growth (NIH 
Publication No.05–2495, December 2004). 
• α Adrenergic blockers: (Parsons et al., 2007) 
• Terazosin is a safe and effective treatment for lower ureteral stones. By 
using this medication, stone passage rate increases and the time of 
stone passage and the need for intervention decreases (Mohseni et al., 
2006). Also Tamsulosin (Sayed et al., 2007) and doxazocin are equally 
efficacious (Yilmaz et al., 2005). 
• Calcium channel blockers: (Singh et al., 2007) 
 Many studies have proven the efficacy of medical expulsive therapy with 
 nifedipine. Because of their specific action on ureteral smooth muscle in 
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 association with anti-edema drugs, it is good in expelling ureteral stones 
 (Micali et al., 2006). 
• Others: 
 Hydroxyprogesterone, prostaglandin synthetase inhibitors, and 
corticosteroids  may have some beneficial effect (Healy et al., 2005). 
 
b. Surgeries: 
 Extracorporeal shock wave lithotripsy (ESWL) 
This is the most common method of dealing with kidney stones. The kidney 
stone is located using X-ray imaging or ultrasound scanning (Sandhu et al., 
2003). 
 
Procedure: 
While patient is lying down, a machine called a lithotriptor sends targeted 
shock waves to break up the kidney stone into crystals small enough to be 
passed in urine. Patient may feel some pain as the stone breaks up, so the 
procedure is usually 
performed under local 
anaesthesia. It was 
found that shock wave 
trauma is primarily a 
vascular lesion, that 
injury is dose dependent 
and that hemorrhage 
can be severe and can 
lead to a permanent loss 
of functional renal mass. 
Studies of the renal functional response to lithotripsy have shown that shock 
wave treatment triggers vasoconstriction in the kidney. This finding has been 
turned to advantage and it is now known that when treatment is begun using 
low amplitude pulses, subsequent high amplitude shock waves are far less 
damaging. Thus, when shock waves are delivered judiciously, treatment can 
have a protective effect. The finding that cavitation is a key mechanism in 
vessel rupture has led to the development of novel experimental methods of 
shock wave delivery that can suppress bubble expansion and minimize 
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tissue damage. Progress has also been made in understanding the physical 
mechanisms involved in stone comminution, and it is seen that the forces 
generated by cavitation, shear stress and circumferential squeezing act 
synergistically to fragment stones. Recent work suggests that a broad focal 
zone may be an advantage, allowing stones to be broken with lower 
amplitude pulses. Cavitation has been shown to play a critical role in 
reducing stone fragments to a size that can be voided. Cavitation is also the 
factor that limits the rate at which treatment can be performed, as stones 
break significantly better at slow rate than at fast rate. There is great interest 
in developing new technology, and in finding ways to improve how lithotripsy 
is performed (McAteer et al., 2005). Thus, recently it has been proved that 
SWL at 90 shocks/min can yield better outcomes than SWL at 120 
shocks/min, particularly in patients with stone lengths > or = 10 mm (Li et al. 
2007). It is not necessary to obtain an IVU for patients who have renal calculi 
with no or minimal back pressure before scheduling them for SWL, thus 
minimizing the cost, avoiding exposure to contrast medium and reducing 
radiation exposure (Sameh, 2007). Earlier it was a question whether ESWL 
success rates are affected by hydronephrosis but now El-Assmy et al., 2007 
have cleared that in patients with solitary distal ureter stones, the degree of 
hydronephrosis caused by the stone does not affect the overall treatment 
success with shock wave lithotripsy. However, stones in obstructed systems 
tended to require repeat treatment and prolonged time for stone clearance. In 
delayed extracorporeal shock wave lithotripsy (ESWL) treatment, increasing 
stone impaction is associated with delayed stone clearance. There was a 
doubt whether colic patients treated by rapid ESWL have the same time to 
stone clearance as noncolic patients. So a study is done and found that 
treatment outcome and time to stone clearance after rapid ESWL in colic 
patients compared with noncolic patients is comparable and independent of 
concomitant hydronephrosis. This finding suggests an absence of significant 
impaction in proximal ureteral stones treated within 24h after a first colic 
episode, enforcing the concept of performing rapid ESWL in patients 
harbouring proximal ureteral stones (Seitz et al., 2007). 
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Medical therapy following ESWL can be used to facilitate ureteral stone 
expulsion resulting in increased 1- and 2-month stone-free rates and in a 
lower percentage of those needing re-treatment. Deflazacort given after an 
ESWL procedure can increase the success rate of ureteral stone treatment 
and also decrease the total consumption of analgesic (Porpiglia et al., 2002). 
Nifedipine is effective on upper middle ureteral stones, and tamsulosin on 
lower ureteral stones, both associated to ketoprofene as anti-edema agent 
(Micali et al., 2007). 
 
Drawbacks: 
Complications may occur with ESWL. Most patients have blood in their urine 
for a few days after treatment. Bruising and minor discomfort in the back or 
abdomen from the shock waves are also common. To reduce the risk of 
complications, doctors usually tell patients to avoid taking aspirin and other 
drugs that affect blood clotting for several weeks before treatment. Another 
complication may occur if the shattered stone particles cause discomfort as 
they pass through the urinary tract. In some cases, the doctor will insert a 
small tube called a stent through the bladder into the ureter to help the 
fragments pass. Sometimes the stone is not completely shattered with one 
treatment and additional treatments may be needed. ESWL is not ideal for 
very large stones. (NIH Publication No. 05–2495 December 2004).The Stone 
free rate after ESWL for renal stones are found to be significantly lower in 
older patients. However, age does not affect the success rate in ureteric 
stones (Ng CF et al., 2007).  
 
Novel ESWL: 
The novel systems are introduced that produce two similar shock waves 
(tandem shock waves) generated with a short time delay. The second shock 
wave arrives during collapse of the bubbles generated in the neighborhood of 
the stone due to the first shock wave. This may increase cavitation bubble 
collapse and could enhance cavitation induced damage to kidney stones 
during shock wave lithotripsy. In vitro comparison of standard systems with 
the new designs showed that fragmentation efficiency of artificial kidney 
stones was significantly enhanced using tandem shock waves (Loske et al., 
2005). Tandem pulses of conventional or modified shock waves produced 
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peak stresses in the front and back halves of the renal calculi. However, the 
single shock wave pulses generated significant peak stresses in only the 
back halves of the renal calculi. It is concluded that for direct stress wave 
induced fragmentation, modified shock waves should be as effective as 
conventional shock waves. And, with a small interval of 20 microseconds 
between the pulses, tandem pulse lithotripsy using modified or conventional 
shock waves could be considerably more effective than single pulse 
lithotripsy for fragmenting kidney stones (Tham et al., 2007). 
Synchronous twin-pulse ESWL is a promising, safe and effective method for 
treating patients with renal and upper ureteric lithiasis. The exclusion criteria 
for it includes lower ureteric stones, patients with urinary tract infection, 
obstructed urinary tract distal to the stones, or congenital abnormalities. In a 
follow up study, there was found no evidence of haematoma, gross renal 
injury, upper urinary tract obstruction or significant changes in the laboratory 
investigations (Sheir et al., 2005). 
 
A new transportable extracorporeal shock wave lithotripsy (ESWL) 
machine, the Modulith SLX-F2(TM) (Storz Medical Italia, Rome, Italy), is 
introduced for the management of solitary urinary calculi. This transportable 
lithotripter is a safe and effective device for managing solitary stones 
throughout the urinary tract. Moreover, it shares with other contemporary 
machines several important features such as outpatient setting, no need for 
anaesthesia, easy patient positioning and the capability of ancillary 
procedures (De et al., 2007). 
 
 Percutaneous nephrolithotomy (PCNL) 
Percutaneous nephrolithotomy was first performed in 1976. In the past 30 
years, many refinements to the procedure have been made and it has 
become the gold standard for the management of large and complex renal 
calculi (Deane et al., 2007). In patients treated with PCNL by LithoClast 
Master/Ultra it is found that large stone burden is a prognostic factor 
predicting longer surgery and prolonged hospitalization. In addition, patients 
with lower BMIs might be at higher risk of not being stone free at hospital 
discharge accompanied by prolonged inpatient treatment (Olbert et al., 
2007). Metaplastic bone formation in the renal pelvis is frequently seen in 
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kidney patients undergoing PCNL. The pathogenesis of this phenomenon is 
not clearly understood. But recognition of extraosseous bone is important, 
since it has implications for management and prognosis (Samad et al., 
2007). 
 
Percutaneous nephrolithotomy is advantageous as it causes minimal renal 
injury and maximizes stone clearance, especially in patients with complex 
stone disease. Although nephrostomy drainage tubes have always been 
placed after percutaneous nephrolithotomy, there may be specific indications 
for tubeless percutaneous nephrolithotomy (Lim et al., 2003). 
 
Procedure: 
Large stones can be surgically removed from the kidney. The surgeon makes 
a small cut in patient’s back and uses a 
telescopic instrument called a 
nephroscope to pull the stone out or 
break it up with shock waves or a laser. 
PCNL is performed under general 
anesthesia. The instillation of Tisseel 
fibrin glue was safe for tubeless percutaneous nephrolithotomy. It was 
associated with less postoperative pain and a lower analgesic requirement 
(Shah et al., 2006). Gelatin sealant packing is also available as a good 
alternative for preventing bleeding and urine leakage postoperatively in 
selected patients receiving tubeless PCNL (Yu, 2006). Now gelatin matrix 
hemostatic sealant is available in a new application device by which the renal 
parenchymal tract of the mini-PCNL can be sealed in 15 to 50 seconds 
(Nagele et al., 2007). 
 
Antegrade pyelography (AGP), plain film radiography (KUB film), and 
noncontrast thin-slice abdominal CT can be used for detecting residual 
stones after percutaneous nephrolithotomy (PCNL). But noncontrast thin-
slice abdominal CT is the most accurate imaging method to determine the 
stone-free rate after PCNL. Noncontrast abdominal CT gives accurate 
information for selecting patients who may benefit from additional treatment 
and for planning follow-up (Park et al., 2007).  
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  Uses: 
PCNL is a valuable treatment for the complete staghorn stones with a stone 
free rate approaching that of open surgery. Moreover, it has the advantages 
of lower morbidity, shorter operative time, shorter hospital stay and earlier 
return to work (Al-Kohlany et al., 2005). Tubeless PCNL was safe and 
effective even in patients with a solitary kidney, or with three renal access 
tracts or supracostal access, or with deranged renal values and in those 
requiring bilateral simultaneous PCNL (Shah et al., 2005). 
PNL is equally efficacious in obese and morbidly obese patients in yielding 
stone free rates. The complication rate and length of hospital stay are also 
similar (El-Assmy et al., 2007). Sergeyey et al., 2007 also proved that in 
patients with kidney stones undergoing PCNL, the stone-free outcome and 
associated morbidity of PCNL (except for the length of hospital stay) is 
independent of both patients' BMI and stone burden when stratifying by 
commonly defined parameters. PCNL gives comparable results even in the 
very young child, children with anatomically abnormal kidneys, children with 
impaired renal function and children with bilateral renal stones undergoing 
simultaneous bilateral PCNL (Samad et al., 2006). 
 
 Ureteroscopic stone removal 
Procedure: 
If a stone is lodged in the ureter, 
a narrow, flexible instrument 
called a cystoscope can be 
passed up through the urethra 
and bladder. The stone is 
captured and removed, or broken 
up with a laser beam or shock 
waves generated by a device 
attached at the end of the 
cytoscope. This procedure is 
usually done under a general 
anaesthetic. Lower pole stones less than 20 mm can be primarily treated by 
ureteroscopic means in patients: that are obese; have a bleeding diathesis; 
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with stones resistant to shockwave lithotripsy (SWL); with complicated intra-
renal anatomy; or as a salvage procedure after failed SWL. Lower pole 
calculi are fragmented with a 200 micron holmium laser fiber via a 7.5 F 
flexible ureteroscope. For those patients where the laser fiber reduced 
ureteroscopic deflection, precluding re-entry into the lower pole calyx, a 1.9 F 
nitinol basket is used to displace the lower pole calculus into a more 
favorable position, thus allowing for easier fragmentation (Preminger, 2006).  
 
Drawbacks: 
Although ureteroscopic treatment of renal calculi is safe and effective, it is 
relatively inefficient compared with ESWL and PCNL.  
 
Uses: 
It should be considered primary therapy for patients with lower pole stones 
who have adverse ESWL characteristics and patients who are not suitable 
candidates for PCNL. There are also numerous clinical situations, as outlined 
previously, where the ureteroscopic approach is favored over other treatment 
modalities (Busby et al., 2004). It achieves improved access to stones 
throughout the pediatric urinary tract and stone-free rates that are 
comparable to the adult population and so has become first line therapy in 
children (Samad et al., 2006). 
 Laparoscopic surgery 
Laparoscopic pyelolithotomy, although uncommonly performed, may be 
considered in patients who have renal anomalies, are poorly compliant, and 
have a large single renal-pelvic calculus. Laparoscopic pyelolithotomy can be 
done safely, effectively and efficiently with proper patient selection and 
adherence to standard laparoscopic surgical principles (Kramer et al., 2007). 
It is effective for complex renal stones and allows for adjunctive procedures. 
It can also be an alternative to percutaneous nephrolithotomy. It 
complements other minimally invasive procedures and a need for open stone 
surgery should be rare in the future (Nambirajan et al., 2005). Although 
minimally invasive stone therapies such as shockwave lithotripsy, 
ureteroscopy and percutaneous nephrolithotomy are efficacious, these 
techniques are not free of risks and are relatively expensive. Watchful waiting 
may be appropriate in patients without infection whose pain can be controlled 
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with oral medication but is associated with pain, uncertainty, potential risks to 
renal function and time lost from work (Healy et al., 2005). 
 
c. Herbal drugs: 
Herbal remedies that have anti-lithiatic (stone-dissolving) action can assist in 
dissolving small kidney stones. These drugs are recommended to increase 
the amount of urine and to relieve pain. Such herbal drugs are gravel root 
(Eupatorium purpureum), hydrangea (Hydrangea arborescens), wild carrot 
(Daucus carota). Starfruit (Averrhoa carambola), Patharvel (Bryophyllum 
pinnatum) and many more. 
 
Phyllantus niruri inhibits calcium oxalate crystallization may be because of 
higher incorporation of GAGs into the calculi (Micali et al., 2006). It also 
reduces CaOx crystal growth and aggregation by the formation of a less 
adherent dihydrate CaOx crystalline structure (Barros et al., 2003).  
 
Administration of the Aqueous and Alcoholic extracts of Moringa oleifera 
root-wood to rats with ethylene glycol induced lithiasis, also reduces and 
prevents the growth of urinary stones as reported by Kardi et al., 2006. 
 
2.2.10 METHODS OF CHEMICAL ANALYSIS OF KIDNEY STONE 
 
Knowledge of the composition of urinary stone is important because 
urolithiasis is a recurrent disease in many people and preventive measures 
must be based on such information. In stones of mixed composition 
knowledge of the structure, as well as of the composition, may be important 
in delineating pathogenesis. Analysis by the crystallographic techniques of 
FTIR spectroscopy and x-ray diffraction photography permit accurate 
identification of all parts of the stone, including a very small nucleus and are 
preferable to chemical methods.  
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Biominerals entering the composition of kidney stones. 
 
Class of 
biominerals 
Minerals Chemical formula 
Oxalates 
Whewellite 
Weddelite  
CaC2O4.H2O 
CaC2O4.2H2O 
Phosphates 
Apetite 
Carbonate apatite 
Hydroxyapatite 
Struvite 
Newberyite 
Wavellite 
Brushite  
Ca3(PO4)2 
Ca3(PO4.CO3)3(OH) 
Ca5(PO4)3(OH) 
NH4MgPO4.6H2O 
MgHPO4.3H2O 
Al3(PO4)2(OH,F)3.5H2O 
CaHPO4.2H2O 
Urates 
Uric acid 
Ammonium urate 
C5H4N4O3 
C5H4N4O3(NH4)2 
Others Quartz SiO2 
Organic 
biominerals 
Cystine  [C3H6NO2S]2 
 
There are many useful techniques that can be used to obtain the urinary 
calculi composition, including chemical analysis (Prien et al., 1968), infrared 
spectroscopy (Channa et al., 2007; Paluszkiewicz et al., 1988), X-ray powder 
diffraction (Orlando et al., 2008) and thermal analysis (Afzal et al., 1992).  
 
FTIR METHOD FOR ANALYSIS OF KIDNEY STONE  
The materials for this study were kidney stones surgically recovered from 
patients. All stones removed during surgery were placed on sterile wire 
gauze to air dry, transferred into a paper plastic envelope bearing the sample 
number. All specimens were first washed carefully with distilled deionised 
water and dried over silica gel for several days. After noting the 
morphological features such as color, shape, etc kidney stones from each 
patient were cut into quarters using a jeweler’s saw and one quarter was 
used for FTIR spectroscopy. The specimen was grounded with agate pestle 
and mortar. This procedure produced a fine homogenous powder which was 
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then stored in a sample tube, kept over silica gel in dark until analyzed for 
composition by FTIR in the frequency range 600 -4000 cm-1. To obtain a high 
signal/ noise ratio 32 scan were accumulated for each sample. Initially the 
spectra were fitted for parabolic function. Then RMS (route mean square) 
was calculated between the original spectrum and the one, fitted by the 
function. The area under the fitted spectrum was dividing by the noise RMS, 
which is reported as signal / noise ratio (SNR). The evaluate menu provided 
in the software perform the entire process automatically. Standard spectra for 
most common crystalline compounds Calcium oxalate (Monohydrated), 
Magnesium ammonium phosphate (Hexahydrate), Uric acid, L-Cystine, 
Calcium carbonate etc. were prepared, which were of high quality.  All kidney 
stones were analyzed using the well validated method described by Channa 
et al. in 2007. Typical FTIR spectra of different standards are shown in 
figures, which are compared with the FTIR spectra of some kidney stone 
samples which were matched with the spectra of standards and identified. 
The diagnostic bands identified for calcium oxalate were the strong bands 
around 778.96, 1315.62, 166.87 cm-1, pure uric acid 1638.10 cm-1, 
magnesium ammonium phosphate 2362.67, 1459.29 cm-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.1 FTIR spectra of Calcium carbonate standard 
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 Figure 2.2 FTIR spectra of Calcium oxalate standard 
 
 
  Figure 2.3 FTIR spectra of Uric acid standard 
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 Figure 2.4 FTIR spectra of Magnesium ammonium phosphate  
         standard 
 
 
  Figure 2.5 FTIR spectra of L-cystein standard 
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X RAY DIFFRACTION METHOD FOR ANALYSIS OF KIDNEY STONE  
XRD analysis, used to study the composition of calculi, provides the 
identification of its phases and their type and quantities, allowing for the 
discovery of the origin of the calculi. When X-ray diffraction analysis is carried 
out, there is no need to perform detailed crystallographic analysis of 
biomineral and it is sufficient only to determine its affiliation to one of the 
known classes of kidney stones. Theoretical diffraction patterns of the main 
types of uroliths are significantly different. This circumstance radically 
simplifies the problem of kidney stone analysis directly in human.  
 
Samples 
All kidney stones obtained by surgical procedures. First, all collected calculi 
were dried in a dessicator filled with nitrogen gas at room temperature for 2 
weeks. The calculis were crushed in an agate mortar in order to obtain a fine 
mesh powder (57µm in size).  
 
X-ray diffraction  
X-ray diffraction patterns of the samples were measured in order to obtain 
the phase composition of the renal calculi. The XRD measurements were 
performed with a diffractometer, using a Cu K_ sealed tube working at 40 kV, 
30 mA, a scintillation counter, and a diffracted beam graphite 
monochrometer. The diffraction patterns were recorded in the step scan 
mode at 0.02 steps and at a measurement rate of 2 s/step. The divergence, 
receiving, and scatter slits used were 1/2 °, 0.3 mm and 1/2 ° respectively. 
The diffraction patterns were registered within the angle range from 4 to 
120°2θ. Some of the samples had their diffraction data collected using the X-
ray Powder Diffraction (D10B–XPD) beam line. The wavelength used was 
1.19197(3) Å and selected by a double-bounce Si(111) monochrometer, with 
the first crystal water cooled and the second one bent for sagittal focusing 
using an Na(Tl)I scintillation counter. In both cases, the instrumental 
parameters were obtained from the refinement of standards samples of LaB6 
and Al2O3. The Powder Diffraction File database was used for phase 
identification.  
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2.2.11 RECENT ADVANCES IN UROLITHIASIS 
Many investigators have focused on the role of tubular epithelial cells in 
stone formation. Crystal retention in the nephron has also been considered 
necessary for stone formation. It has been found that calcium oxalate 
crystals can bind to renal epithelial cells. Moreover, available evidence 
suggests that oxalate and/or calcium oxalate crystals can damage renal 
epithelial cells and enhance crystal binding. Concurrently, oxalate exposure 
induces genes coding macromolecular inhibitors, which are supposed to be a 
protective mechanism against stone formation. Thus, understanding of the 
mechanisms involved in kidney stone formation could lead to new 
therapeutic approaches to preventing stone recurrence. However, clinical 
application of the prophylactic approaches proposed here awaits further 
progress in basic research using rapidly growing new technologies. 
Application of the DNA microarray technique to the rat stone model may 
provide a clue to understanding stone forming process at the genetic level. In 
addition, case-control association analysis using single nucleotide 
polymorphism as a marker may be useful for detecting susceptibility genes in 
patients with calcium stone disease (Kohjimoto et al., 2004). 
 
Crystallization, with risk of renal damage and kidney stones, appears to be 
affected by molecules in urine that retard nucleation, growth, aggregation 
and renal cell adherence of CaOx. A 28-kDa protein was purified from urine 
using salt precipitation, preparative isoelectric focusing and sizing 
chromatography. Amino acid composition and NH2-terminal amino sequence 
analysis showed complete homology to calgranulin. Calgranulin was found to 
be a potent inhibitor of CaOx crystal growth (44% of control) and aggregation 
(50% of control) in the nanomolar range. Calgranulin cDNA was cloned from 
a human kidney expression library. Western analysis of human and rat 
kidney homogenates and mRNA temporal expression from two independent 
renal epithelial cell lines showed that calgranulin is produced in the kidney. 
Given its urinary abundance and potency, calgranulin may contribute 
importantly to the normal urinary inhibition of crystal growth and aggregation 
and therefore to the renal defense against clinical stone disease (Sokalingum 
et al., 1998). 
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The influence of urinary proteins on adhesion of preformed calcium oxalate 
crystals to rat continuous inner medullary collecting duct (cIMCD) cells was 
studied in vitro, and cIMCD cells were also exposed to calcifying media 
containing beta-glycerophosphate for up to 28 days. Renal tissue was 
obtained from a stone-forming and non-stone-forming individual at the time of 
nephrectomy. These nanoparticles, isolated from renal stones obtained at 
the time of surgical resection, were analyzed and propagated in standard cell 
culture medium. It was found that urinary proteins influence crystal adhesion 
to renal epithelial cells and this activity is abnormal in the urine of stone-
forming patients. cIMCD cells assumed an osteoblastic phenotype when 
exposed to the calcifying medium, expressing two bone matrix proteins 
(osteopontin and bone sialoprotein) that were also identified in the kidney of 
the stone-forming patient and associated with crystal deposition. 
Nanoparticles were propagated from the majority of renal stones. Isolates 
were susceptible to selected metabolic inhibitors and antibiotics and 
contained conserved bacterial proteins and deoxyribonucleic acid (DNA). 
These suggested new paradigms for Randall's plaque formation and 
idiopathic calcium oxalate stone disease. It seems unlikely that these events 
are driven solely by physical chemistry; rather, they are critically influenced 
by specific proteins and cellular responses and understanding these events 
will provide clues toward novel therapeutic targets (Kumar et al., 2006). 
 
Calculi are commonly found attached to the renal papilla in calcium oxalate 
(CaOx) stone formers, but the mechanisms by which stones form in this 
manner are not well established. A study was carried out and three attached 
stones were collected from different patients. Stone morphology and 
composition were determined using micro computed tomography (CT) and 
infrared microspectrometry. It was then found that one of the stones was 
composed of CaOx with a peripheral region of apatite, such as might have 
come from a Randall's plaque. Another stone was covered with large CaOx 
crystals but contained at least two layers of apatite, with no apatite regions 
exposed at the surface. The third stone contained CaOx with inclusions of 
apatite and more apatite on its surface, along with a substantial volume of 
poorly mineralized material that could not be identified. The complexity of 
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these stones and their differing morphologies do not by themselves allow 
inference of the mechanism of stone formation. So future work will require 
the careful documentation of attached stones on the papilla, as well as study 
of the papilla after the stone has been removed, before it can be determined 
whether such diverse CaOx stones originate from the same or different 
underlying etiologies (Williams et al., 2006). 
 
Calcium oxalate monohydrate (COM) binding protein (45 kDa) is a promoter 
of calcium oxalate kidney disease, which is markedly up regulated by oxalate 
induced oxidative stress. A study was done and found that COM binding 
protein can serve as a diagnostic marker for CaOx stone formers (Asokan et 
al., 2004). Global warming may raise kidney stone cases reported in a study 
in 2008. 
 
The influence of citrate and certain urinary proteins on adhesion was 
examined by Xiaoxia et al and it was curious that osteopontin, a suspected 
regulator of stone formation, increase the adhesion force between a 
carboxylate tip and the (100) crystal face. Studies with renal tubular cells by 
Marino et al., 2003 in culture indicate that hyaluronan (HA) and 
osteopontin(OPN) and their mutual cell surface receptor CD44 play an 
important role in calcium oxalate (CaOx) crystal binding during wound 
healing.     
 
In a study Elena et al. in 2004 demonstrate that nucleolin is expressed on 
both apicaland basolateral cell surfaces of inner medullary collecting duct 
(cIMCD), reaching a peak in thelate stages of mitosis and gradually declining 
to undetectable levels with maturation of the polarized epithelium. The results 
demonstrate that surface-bound acidic Factor can mediate CaOx attachment 
and that secreted Acidic Factor can inhibit attachment. 
 
Wasserstein et al. in 1987 concluded that urine calcium excretion is a major 
risk factor for idiopathic calcium stone formation, but cannot confirm such a 
role for urine uric acid excretion. In a study by Tang et al. 2006 they show 
that brushite may play crucial roles in the formation of COM crystals. Two 
roles for brushite thereby provides physicochemical explanations for the 
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initiation of COM crystallization and also for the relative paucity of calcium 
phosphate detected in the majority of CaOx renal stones. 
 
If magnesium citrate and magnesium oxide are to be used in the 
management of recurrent calcium oxalate nephrolithiasis, they should be 
administered with meals studied by Lindberg et al. in1990. 
 
Cell membrane fragments derived from renal tubular epithelial cells are 
common in the human urine. They contain phospholipids such as 
Sphingomyelin (SM), Phosphatidylethanolamine (PE), Phosphatidylserine 
(PS), Phosphatidylcholine (PC) and Phophatidylinositol (PI) that can promote 
nucleation of CaOx crystals. Brush Border Membrane (BBM) can be enriched 
with specific phospholipids to determine which phospholipid is involved in 
crystal nucleation. Study by Calero et al in 2000 demonstrated that relative 
supersaturation of BBM enriched with PE and PC titrated at a faster rate 
when compared to the normal BBM. Membrane enriched with PI, SM and PS 
titrated at a slower rate when compared to the normal BBM. COM crystals 
can bind within seconds to anionic, sialic acid-containing glycoproteins on the 
apical surface of kidney epithelial cells in culture, suggesting one mechanism 
whereby crystals could be retained in the tubule.  
 
It is proposed by Khan et al. in 1987 that crystal nuclei were formed by 
heterogeneous nucleation. These nuclei then adsorbed organic material and 
aggregated. The organic material polymerized resulting in the formation of a 
crystal-matrix unit which then grew and incorporated more organic material 
during the crystal growth. They reported that urine as well as CaOx and CaP 
crystals made in the urine and various types of urinary stones investigated 
contained some lipids. Urine of both CaOx and uric acid stone formers 
contained significantly more cholesterol, cholesterol ester and triglycerides 
than urine of healthy subjects.  
 
On the calcium-rich mineral water, urinary saturation with Whewellite was 
lower and it hardly reached the critical level for calcium oxalate crystallization 
after oxalate loading, which was in contrast to the results on low calcium 
mineral water. Urinary Brushite saturation was generally low and showed no 
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significant differences between the two mineral waters reported by 
Ackermann et al. in1988.  
 
The inhibition of calcium oxalate crystal growth by allopurinol was measured 
in an in vitro system and the inhibition index increased from .51 +/- .06 to .57 
+/- .08 (mean +/- SD). This is indicated by Tiselius et al., 1990 
 
The direct evidence given by Lyons et al., 2001 that crystals generated from 
cell-free systems contain significant amounts of protein distributed 
throughout a complex internal structure.  
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3. AIM OF PRESENT WORK 
 
The increasing number of the people suffering from kidney related disease is 
evidence in itself for the lack of awareness among the general public.   
 
 Geography plays a part with more stones noted in certain region. Water 
properties in different localities are different which increase the risk of 
stone formation when contains high amount of minerals. The overall 
probability of forming stones differs in various parts of the world: 1-5% 
in Asia, 5-9% in Europe, 13% in North America, 20% in Saudi Arabia.  
 
 There are many regions in Saurashtra where significant numbers of 
people are observed with kidney stone disease and hence these 
regions is called ‘stone belt’. Present work is aimed to analyze the 
kidney stone problem in this region. The work was planned with 
following Objectives; 
 
1. To study the risk factors of kidney stone in Saurashtra region. 
 AGE   
 GENDER   
 WEIGHT   
 OCCUPATION  
 TYPE OF WATER  
 QUANTITY OF WATER  
 FOOD  
 HABITUATION  
 OTHER DISEASE 
 
2. To determine type of kidney stone prevalent in this region using various 
analytical techniques. 
 X RAY DIFFRACTION  
 FTIR SPECTROSCOPY  
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3. To study crystallization and solubility of the major kidney stone 
component in different medium. 
 EFFECT OF URINARY ELECTROLYTES ON CALCIUM 
OXALATE STONE FORMATION  
To study effect of ionic strength and mean activity co-efficient of 
different urinary electrolytes like potassium chloride, sodium 
chloride and magnesium sulphate on CaOx crystallization.  
 
 EFFECT OF CHELATING AGENTS ON SOLUBILITY OF 
CALCIUM OXALATE STONE 
Chelation therapy is now a day’s expanding its applications in 
various treatments. Calcium chelation with citric acid and lactic 
acid like biomolecules and disodium edetate can play a major 
role in chelation therapy of nephrolithiasis. So, the aim is to 
analyze the effect and prospect of chelating agents in urological 
calcium oxalate calculi dissolution.  
 EFFECT OF CHELATING BIOMOLECULES ON 
SOLUBILITY OF CALCIUM OXALATE 
 EFFECT OF DISODIUM EDETATE ON SOLUBILITY OF 
CALCIUM OXALATE  
 
 EFFECT OF pH ON SOLUBILITY OF CALCIUM OXALATE 
pH plays an important role in dissolution of weak electrolytes. 
Study of effect of pH on solubility of calcium oxalate is still to be 
lightening on. Determination of composition of kidney stone 
shows that calcium oxalate is the major component present. In 
present study attempt has been made to understand effect of pH 
on solubility of calcium oxalate crystals. pH range selected for 
the study was the urinary pH range. 
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4. ANALYSIS OF RISK FACTORS OF KIDNEY STONE IN 
PEOPLE OF SAURASHTRA REGION 
 
4.1 INTRODUCTION 
 
Kidney stones are a major cause of morbidity. The lifetime prevalence 
of symptomatic nephrolithiasis is approximately 10% in men and 5% in 
women (Stamatelou et al., 1994; Johnson et al., 1979; Hiatt et al., 
1982), and more than $2billion is spent on treatment each year (Pearle 
et al., 2004; Lingeman et al., 1986). About 80% of kidney stones 
contain calcium, and the majority of calcium stones consist primarily of 
calcium oxalate (Coe et al., 1992; Levy et al., 1995). The identification 
of common, modifiable risk factors for kidney stones may result in new 
approaches to treatment and prevention. The major risk factors are 
age, sex, body weight, hereditary or personal history of renal stone, 
geographic conditions, life style factors, associated diseases, 
medications etc. 
 
The peak age of onset of kidney stone occurrence is between 20 and 
30 years (NIH Consens statement). In older women and men, greater 
intakes of dietary calcium, potassium, and total fluid reduce the risk of 
kidney stone formation, while supplemental calcium, sodium, animal 
protein and sucrose may increase the risk (Curhan et al., 2005; Curhan 
et al., 1997). Normal women excrete more citrate and less calcium than 
normal men, perhaps a reason why men form stones more often. Four 
of every five patients with stones are men. (NIH Consens statement). 
 
The association between calcium intake and kidney stone formation 
varies with body size (Taylor et al., 2004). Larger body size may result 
in increased urinary excretion of calcium, oxalate, and uric acid, 
thereby increasing the risk for calcium-containing kidney stones. 
Obesity and weight gain increase the risk of kidney stone formation. 
The magnitude of the increased risk may be more in women than in 
men (Taylor et al., 2005). 
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Geography plays a part with more stones noted in the southeast, also 
known as the stone belt. Water properties in different localities are 
different which increase the risk of stone formation when contains high 
amount of minerals. The overall probability of forming stones differs in 
various parts of the world: 1-5% in Asia, 5-9% in Europe, 13% in North 
America, 20% in Saudi Arabia. The composition of stones and their 
location in the urinary tract, bladder or kidneys may also significantly 
differ in different countries. Moreover, in the same region, the clinical 
and metabolic patterns of stone disease can change over time 
(Ramello et al., 2000). 
 
Dietary factors play an important role in kidney stone formation and 
have fluctuated markedly over the centuries. Another hint that nutrition 
may be an important determinant of stone formation comes from the 
clinical presentation of stone disease. The role of many nutrients like 
calcium, oxalate, magnesium, phosphorus, sodium, potassium, protein 
and dietary phylates has been investigated in the last years, because of 
their known effect upon urinary excretion as either promoters or 
inhibitors of stone formation (Taylor et al., 2004).  
 
There is relatively increased risk in subjects with family history for 
calculosis (Amato et al., 2004). Around half of all people who have 
previously had a kidney stone will develop another one within five 
years. Genetically inherited disorders account for some stone 
formation. Low urine pH from hereditary causes promotes uric acid 
stones. Cystine stones occur only in cystinuria, a hereditary disorder of 
amino acid transport. A slightly higher rate of renal stone disease 
emerged in white Caucasians than in Blacks (Ramello et al., 2000).  
 
Diseased conditions like several Bowel diseases increase calcium 
phosphate supersaturation. The propensity for renal stone formation is 
increased in patients with Crohn's disease due to increased urinary 
oxalate and decreased urinary magnesium and citrate concentrations 
(Böhles et al., 1988). Renal tubular acidosis increases calcium 
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phosphate supersaturation. Struvite supersaturation occurs only when 
urine is infected with microorganisms that possess urease, and are 
rightly called "infection" stones. However, additional studies are needed 
to determine if the increased risk of Diabetes mellitus in stone formers 
is due to subclinical insulin resistance (Taylor et al., 2005). People 
having a disease of the small intestine or a small intestinal bypass or 
people having only one kidney or an abnormally shaped kidney are 
more prone to have renal stones. Recurrent urinary tract infections, 
indwelling catheters, vesicoureteral reflux, and immobilization 
hypercalcuria are a few of the major risk factors for the development of 
urolithiasis among spinal cord injury patients. Retrograde endourologic 
techniques are often not possible to address stone disease due to 
lower extremity contractures, spinal curvature, and pelvic tilt. Early 
identification and treatment of urolithiasis in spinal cord injury patients 
can so aid in preserving renal function and minimizing associated 
complications (Ost et al., 2006). People being regularly dehydrated or 
those having very poor mobility (e.g., being confined to bed) have more 
chances to suffer from nephrolithiasis. A high frequency of stone 
formation among hypertensive patients has been reported (Ramello et 
al., 2000). Whereas it has been already proved that an independent 
clinical association exists between the occurrence of urolithiasis and 
hypertension and the increased urinary calcium excretion commonly 
detected in hypertension may be the pathogenetic link (Cappuccio et 
al., 1990). 
 
Certain medicines such as diuretics, antacids and thyroid medications 
increase calcium concentration in urine. Certain drugs like 
sulphamethoxazole, phenytoin, trimethoprim, indinavir, etc can form 
stones. Medications such as antacids that alter urine pH may increase 
susceptibility for kidney stones. Calcium and mineral supplements also 
affecting the kidney stone formation.  
 
Tobacco addiction is the other risk factor considered for the people of 
Saurashtra in this work. As the people of Saurashtra are having habit 
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of chewing betel quid and the frequency per day is also very high. The 
betel leaf is predominantly consumed in the world as betel quid or 
paan, which primary consists of lime, areca nut etc. (Mark,  2001).  
 
In the present study affords has been made to study risk factors of 
kidney stone in people of Saurashtra region, which could be helpful for 
prevention and treatment of kidney stone. The controllable factors 
could be helpful in designing lifestyle of people of Saurashtra which 
could decrease the reoccurrence rate. 
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4.2 METHOD 
 
There are many methods of collecting primary data and the main 
methods include: questionnaires, interviews, focus group interviews, 
observation, case-studies, diaries, critical incidents and portfolios. In 
this study the questionnaires were used for the collection of data. A 
questionnaire was prepared including the questions related to the risk 
factors. The data was collected from patients of B.T.Sawani Kidney 
Hospital and from various patients taking treatments under various 
urologists through questionnaire. 50 patients were selected randomly 
and questionnaires were filled by the answers given by the patients. 
Collected data was analyzed for different risk factors as following. 
 
4.2.1 Age:  Patient’s age was divided in four range groups: upto 20 
years, 21 to 40 years, 41 to 60 years and 61 years and above. 
Patient’s data was classified in these four ranges. A graph was 
plotted: percentage of patients in particular range vs. age groups 
(Figure 4.1) (Table 4.1). Patient’s data was compared with age 
wise percentage of Indian population. 
  
4.2.2 Gender:  Stone patients were dispersed in two genders. 
Analysis of effect of sex on kidney stone formation was made 
(Figure 4.2) (Table 4.2). Percentage of patients falling in 
different sex group was compared with percentage saurashtra 
population sex distribution. 
 
4.2.3 Weight:  The patients were categorized according to their 
weight in eight different groups. Effect of weight on kidney stone 
formation was evaluated (Figure 4.3) (Table 4.3). 
 
4.2.4 Occupation:  The data was scattered occupation wise in four 
categories according to their work category. 
a) People working on daily wages/ farmers 
b) Service class people  
c) Business class 
d) Others  
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 Analysis effect of work on kidney stone was attempted (Figure 
4.4) (Table  4.4).   
 
 
4.2.5 Water:  Three types of analysis were done for water.\ 
 
TDS in water:  Bore water and municipal water of different 
major cities were tested for total dissolved solids. Sample 
for bore water and municipal water were collected (n=5) 
from the seven major cities of Saurashtra. They were 
analyzed for TDS level. Variation was observed in TDS 
level of bore water and municipal water in major sities of 
saurashtra (Figure 4.5) (Table 4.5). 
Type of water:  Patients were disseminated in three 
categories. Those drinking bore water, municipal water or 
other source of water. Observations are studied for the type 
of water kidney stone patients consuming (Figure 4.6) 
(Table 4.6). 
Quantity of water:  Patients were sorted into three clusters 
according to the quantity of water they are drinking. 
I) 1 liter 
II) 2 to 3 liter 
III) 4 to 5 liter  
Quantity of water consumed was scrutinized as risk factor 
for kidney stone formation (Figure 4.7) (Table 4.7). 
 
4.2.6 Food: Data collected from questionnaire to patients about their 
routine diet subdivided into two major categories of food they 
were taking 
a) Food causing risk of kidney stone formation. 
b) Food inhibiting risk of kidney stone formation / have less 
chances of kidney stone formation. 
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Number of kidney stone patients was dispersed in these 
categories according to their major food habit. Diet as risk factor 
studied form the food habit of patients (Figure 4.8) (Table 4.8). 
 
4.2.7 Habituation: Patients were scattered in six addiction habits 
which are very common in saurashtra. They were Cigarette / 
Bidi smokers, Tobacco consumers, Tobacco with lime (Ca(OH)2 
adductors, betel quid(paan) with lime consumers, Tobacco 
sneezers, other habituation. Correlation was drawn between the 
habituation and number of kidney stone patients (Figure 4.9) 
(Table 4.9). 
 
4.2.8 Other disease history and medication:  Patients having 
history of other diseases were studied for their relation with 
kidney stone formation. Collected data was analyzed (Figure 
4.10) (Table 4.10).  
4.2.9 Reoccurrence:  Out of 50 patients many had reoccurrence 
history of stone formation was estimated and percentage of 
reoccurrence was calculated.  
 
Statistical analysis 
Significance of the risk factors were studied statistically using chi-
square test. Statistical analysis was performed at significance level of 
0.05. (Table 4.11). 
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4.3 RESULTS AND DISCUSSION  
 
Risk factor analysis of patients of kidney stone of Saurshtra region 
magnifies some aspects of kidney stone formation. The risk factors 
could be categorized in to clusters manageable and unmanageable. 
Weight, food, water, medication and habituation could be manageable, 
while age, gender and other diseases could not be manageable. 
Occupation could be/ could not be manageable.  
 
4.3.1 Age: The kidney stone patients classified according to their age 
groups indicated that maximum percentage of people develops 
kidney stone in the age group 20 to 40 years (51%). Lesser is 
observed in age group 40 to 60 years. The other two groups 
have least tendencies to develop kidney stone. Figure 5.1. It 
was seen that young age people between 20 to 40 years were 
the main cluster who develop kidney stone. In both sexes the 
peak age of onset was observed between 20 and 30 years 
which was also observed in NIH Consensus. 
4.3.2 Gender: Analysis of the patients’ data for their gender shows 
(Figure 4.2) that very high percentage male patients develop 
renal calculi (89%) compared to that female patients (11%). 
Nine of every ten patients with stones were men. This clearly 
indicates that the gender matters much for the development of 
kidney stone. Gender does mean much as reviewed because 
normal women excrete more citrate and less calcium than 
normal men, perhaps a reason why men form stones more 
often. 
4.3.3 Weight: The weight analysis showed that (36%) stone patients 
had weight 51 to 60 kg, 26% patients having weight 61 to 70 kg, 
12% patients having weight between 71 to 80 kg (Figure 4.3). 
This analysis suggested that heavy weight people may have 
more probability of kidney stone formation. This was supporting 
the analysis done by Taylor et al. in 2005 that larger body size 
may result in increased urinary excretion of calcium, oxalate and 
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uric acid, thereby increasing the risk for calcium-containing 
kidney stones. Obesity and weight gain increase the risk of 
kidney stone formation. 
 
4.3.4 Occupation: The distribution of patients in different lifestyle 
groups showed that hard working population such as daily 
wager and farmers was major group which develop kidney stone 
(49%) than service class people (25%) and then come students 
and housewives section of society (22%). The people living 
luxurious life like business class people observed least risk of 
renal calculi formation, (4%). (Figure 4.4) Hard working people 
working on daily wages/farmers need to do much exertion which 
may cause dehydration leading to kidney stone formation. 
 
 
4.3.5 Water: Water analysis was done in three different ways. 
 
TDS in water:  Bore water and municipal water of different 
major cities were tested for total dissolved solids. Sample 
for bore water and municipal water were collected (n=5) 
from the seven major cities of Saurashtra. TDS level of 
Surendranagar was found highest in bore and municipal 
water (Figure 4.5). 
 
In about thousand villages in coastal Saurashtra 
(Gujarat) the TDS levels have risen beyond 2,000  ppm  
(throughout  the  year)  due  to  seawater  intrusion  and  
excessive  groundwater extraction. They have been termed 
as fully saline villages. Seawater intrusion has changed the 
water quality contaminating it with excess salinity and 
different elements such as chloride, calcium, magnesium 
and sodium (Indu et al.).   Prolonged  exposure  to  water  
containing  salts  (TDS  above 500ppm)  can  cause  
kidney  stone,  a  phenomenon  widely  reported  from  
north  and  coastal Gujarat (Kumar et al.). 
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Patients were distributed in three categories accordingly 
the type of water they are drinking. The plot of percentage 
of patients vs. source of water indicates that 64% of 
patients were that drinking water supplied by municipal 
source (Figure 4.6). Patients drinking water from bore were 
29%. Remaining was drinking water from other sources. 
 
To what extent the hardness and mineral composition of 
water affect stone risk remains controversial (Agreste et al., 
1999; Caudarella et al., 1998). As the calcium content of 
drinking water increases, calcium excretion increases, but 
oxalate excretion falls (Caudarella et al., 1998; Marangella 
et al., 1996). 
 
Quantity of water:  Patients were distributed into three 
categories according to the quantity of water they are 
drinking. (1 liter, 2 to3 liter and 4 to 5 liter) 
 
Figure 4.7 shows that the patients drinking up to 1 liter of 
water were highest in number (56%). The patients drinking 
water 2 to 3 liter were 27%. Only 17% of patients were 
drinking 4-5 liter of water per day.  
 
Fink et al: indicated in 2009 high fluid intake decreased risk 
of recurrent nephrolithiasis. Drinking more water at least 8 
to 10 glasses daily is the solution or treatment of kidney 
stone (Sai Gopal, 2011).  
 
4.3.6 Food: In survey high consumption of certain food product were 
found to influence the promotion and inhibition of the kidney 
stone formation. 
 
The percentage of patients falling in various categories was 
observed. Figure 4.8. The food items such as wheat (74%), tea 
(62%), peanut (54%), whole potato (42%), onion (36%) and 
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tomato (22%) were among the promoters of kidney stone. They 
are having high percentage of oxalate content. Compare to 
wheat, rice may prove better grain for kidney patient. On the 
other hand the major inhibitors of kidney stone were milk 
product and lemon. The people of saurashtra region invariably 
take buttermilk in food. Intake of milk product reduces probability 
of stone formation since dietary consumption of calcium inhibits 
absorption of oxalate. Kidney stone patients consumption of 
lemon were also less (14%) (Figure 4.8).  
4.3.7 Tobacco and Lime: Patients of Saurashtra suffering from 
kidney stone disease were found quite heavy influenced by 
tobacco addition. Figure 4.9. Significant number of male 
population in Saurashtra has habit of tobacco smoking, tobacco 
chewing and chewing betel quid with lime [Ca(OH)2]. Direct 
absorption of calcium in systemic circulation may promote 
kidney stone formation. The study of male to female kidney 
stone formers evidently supports these findings. 
 
4.3.8 Other disease history:  Patients of kidney stone with history of 
other diseases were noticed. The analysis of data showed that 
significant numbers of patients were having history of UTI 
infection and GIT disorder. Ulcer and GIT disturbances were the 
other major complaints of the patients (Fig 4.10). Acidity and 
malfunctioning of GIT should be further investigated as the 
reasons for the kidney stone formation in the region. 
 
4.3.9 Other medication taken by the patients could be changed if once 
they develop stone. Calcium supplements they were taking 
could be stopped to prevent reoccurrences.  
 
4.3.10 Reoccurrence: 40 percent of kidney stone patient reported 
reoccurrence. Chi-square value calculated at 0.05 level of 
significance exhibit that there was significant difference between 
the data sets that cannot be due to chance alone. Proper dietary 
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control and 2-3 liters of soft water consumption per day can help 
prevention of reoccurrence. Extensive study is suggested to 
address reoccurrence problem in saurashtra region. 
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Figure 4.1 Effect of Age (Years) observed on renal calculi  
        prevalence 
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Figure 4.2 Patients of renal calculi observed in different gender 
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Figure 4.3 Patients of renal calculi observed in different weight  
        categories  
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Figure 4.4 Patients of renal calculi observed in the different  
        occupation  
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Figure 4.5 TDS in bore and municipal water in major cities of  
          Saurashtra 
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Figure 4.6   Patients of renal calculi drinking different type of  
          water 
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Figure 4.7 Effect of water consumption on renal calculi prevalence 
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Figure 4.8    Effect of diet observed on renal calculi prevalence 
           (n=50) 
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Figure 4.9 Effect of addiction or habituation on kidney stone  
        formation. 
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Figure 4.10 Effect of disease condition of patients on kidney stone  
         formation 
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Table 4.1 Indian population and Observed Percentage of kidney 
stone patients falling in different age groups (n=50). 
 
AGE 
GROUPS 
% INDIAN 
POPULATION* 
% 
PATIENTS 
OBSERVED 
0-20 45.21 11 
21-40 31 51 
41-60 16.32 36 
60-up 7.47 2 
 
*Percentage Indian population age distribution data available from 
www.hsph.harvard.edu/pgda/WorkingPapers/2011/PGDA_WP_65.pdf 
 
 
 
 
 
 
 
 
Table 4.2 Indian population and Observed Percentage of kidney 
stone patients falling of different sex (n=50). 
 
GENDER 
% 
SAURASHTRA 
POPULATION* 
% 
PATIENTS 
OBSERVED 
MALE 51.61 89 
FEMALE 48.39 11 
 
*Percentage saurashtra population sex distribution data available from 
www.indiaonlinepages.com/population/gujarat-population.html 
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Table 4.3 Percentage of kidney stone patients falling in different 
weight groups (n=50). 
 
WEIGHT % OF PATIENTS 
less than 20kg 0 
21 to 30 kg 2 
31 to 40 kg 4 
41 to 50 kg 12 
51to 60 kg 36 
61 to  70 kg 26 
71 to 80 kg 12 
81 kg and more 8 
 
 
 
Table 4.4 Percentage of kidney stone patients of different 
occupation (n=50). 
OCCUPATION 
% OF 
PATIENTS 
PEOPLE WORKING ON DAILY 
WAGES/FARMERS 49 
SERVICE CLASS 25 
BUSINESS CLASS 4 
OTHERS 22 
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Table 4.5 Mean and standard deviation of six observations of the 
analysis of total dissolved solid in bore and municipal water of 
seven major cities of Saurashtra. 
 
MUNICIPLE WATER 
(TDS) (n=5) 
  
BORE WATER 
(TDS) (n=5) 
 
MEAN ± STDEV  MEAN ± STDEV 
356 9.522 RAJKOT 1050 10.93 
866 9.827 JUNAGADH 1130 8.45 
181 6.986 JAMNAGAR 740 12.25 
870 9.196 AMRELI 1800 17.32 
278 8.019 PORBANDAR 1106 12.04 
582 6.218 SURENDRANAGAR 5500 17.32 
290 8.281 BHAVNAGAR 2000 17.32 
 
 
 
 
 
 
 
Table 4.6 Percentage of kidney stone patients drinking different 
type of water (n=50). 
 
TYPE OF WATER % OF PATIENTS 
BORE WATER 29 
MUNICIPAL WATER 64 
OTHER 7 
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Table 4.7 Percentage of kidney stone patients drinking different 
quantity of water (n=50). 
 
 
QUANTITY OF WATER % OF PATIENTS 
1 liter 56 
2 to 3 liters 27 
4 to 5 liters 17 
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Table 4.8 Percentage of kidney stone patients consume maximum 
amount of food that increases the risk of kidney stone formation 
(n=50). 
TYPE OF FOOD NUMBER OF PATIENTS 
TOMATO 11 
SPINACH 3 
GREEN LEAFY VAGETABLES 3 
GREEN CHEELIES 6 
LADIES FINGER 6 
WHOLE POTATO 21 
WHOLE SWEET POTATO 1 
BEET 2 
SURAN 0 
BRINGLE 12 
GREEN PEAS 7 
TEA 31 
COFFEE 3 
CHOCOLATE 1 
COCA-SOFT DRINKS 3 
MILK PRODUCS  27 
PEANUTS 27 
WHEAT  37 
BEANS 2 
BERRIES 1 
STRAWBWRRIES 0 
PLUMS 0 
NUTS 6 
MEAT 1 
FISH 3 
PEANUT OIL 17 
RADISH 0 
LEMON 7 
CHEESE 1 
RADISH 1 
CABBAGE 5 
ONION 18 
RICE 10 
MAIZE 0 
GREEN GRAPES 1 
SALT 8 
BREAD 0 
FASTFOOD 5 
EGGES 0 
OTHER OIL 11 
SALAD 6 
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Table 4.9 Number of kidney stone patients of different habituation 
(n=50). 
 
HABITUATION 
NUMBER  OF 
PATIENTS 
Cigarette / Bidi 
smokers 42 
Tobacco consumers 29 
Tobacco with lime 
adductors 44 
Betel quid with lime 
consumers 42 
Tobacco sneezing 4 
Other categories 2 
 
Table 4.10 Number of kidney stone patients of different other 
diseases (n=50). 
OTHER DISEASES 
NUMBER OF 
PATIENTS 
Diabetes 5 
GIT disorder 12 
High blood pressure 6 
Atherosclerosis 2 
Hyper parathyroidism 4 
Heart disease 4 
Respiratory disease 3 
Kidney disease 7 
Liver disease 1 
UTI infection 14 
Ulcer 9 
Cancer 0 
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Table 4.11  Statistical analysis of risk factors using chi square 
test. 
 
RISK FACTORS df X2c X2t  LEVEL OF 
SIGNIFICANCE 
P=0.05 
AGE 3 66.83 7.815 
X2c> X2t 
 
There IS a 
significant 
difference 
between the 
data sets that 
cannot be due 
to chance 
alone.  
 
GENDER 1 55.98 3.841 
WEIGHT 7 101.09 14.07 
TOBACCO 
HABITUATION 
5 69.82 11.07 
OTHER 
DISEASE 
11 36.34 
19.67
5 
 
X2c = chi square value calculated at 0.05 level of significance 
X2t = chi square value tabulated at 0.05 level of significance 
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5.  DETERMINATION OF COMPOSITION OF KIDNEY STONE  
     PREVALENT IN SAURASHTRA REGION 
 
5.1 INTRODUCTION 
 
NEPHROLITHIASIS, the formation of stones in the urogenital system 
has afflicted humans since antiquity, with the earliest recorded example 
(Whitfield  et al., 1999) being an urinary calculus found in the pelvic 
area of a young man in a tomb near El Amrah (Egypt) dating back to 
4800 BC. Stone disease in man is as old as mankind. This common 
disorder of renal stone formation affects up to 15% of the population 
over a lifetime (Hess et al., 1997) and without proper treatment and 
preventive measures, approximately 75% of these patients will have at 
least one recurrence. An extrapolated incidence statistics of 3,915,700 
kidney stones has been estimated from a population of 1,065,070,607 
persons in India (Saita et al., 2007), an indication of its high 
prevalence. The diagnostic usefulness in knowing the chemical 
composition of renal stones has been recognized since 1950s with 
significant improvement in therapeutic regimen since then, as exact 
determination of the compositional structure enables the classification 
of the disease and its subsequent treatment. Saurashtra is situated in 
the west part of the Gujarat, which consist of seven districts. Rajkot is 
the capital of Saurashtra region. Saurashtra is the dry region of 
Gujarat, with less rain in the season. People who lived in rural area 
depend on groundwater as a major source of water supply. To add to 
this plight, the region lies on the renal stone belt of India. As no 
detailed literature is available on the chemical composition of renal 
stones from this region, that would help design an appropriate post-
operative treatment to prevent stone recurrence, the current study was 
undertaken to arrive at a quantitative picture of the renal stone 
composition. Symptomatic renal stones retrieved by surgical operation 
of 100 patients admitted to the B. T. Sawani Kidney Hospital were 
collected for this study. For renal calculi of size between 1 and 2.5 cm, 
Extracorporeal Shock Wave Lithotripsy (ESWL) was the noninvasive 
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method for treating urinary stones, by generating shock waves outside 
the body and focusing them on the stones. During the treatment, 
stones were fragmented into pieces and rendered small enough to be 
excreted. An endoscopic percutaneous nephrolithotomy (PCNL) was 
used to crush moderate to large stones, with the use of optical 
instruments introduced into the kidneys through a stab wound in the 
loin. First time stone formers, with no structural abnormality in the 
urinary tract, no concurrent infection and no hereditary predisposition to 
stone formation were the inclusion criteria used for patient recruitment 
in this study. The quantitative chemical composition of the pretreated 
stone sample was then arrived at using FTIR Vibrational spectroscopic 
technique (Channa et al., 2007) and x ray diffraction (Orlando et al., 
2008) technique.  A combination of these two techniques provides fast, 
sensitive, accurate and detailed data about the stone composition, 
enabling more reliable and efficient treatment of individual patients 
during postoperative care to prevent recurrence of stones. 
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5.2 EXPERIMENAL  
 
Instrument 
FTIR Spectrophotometer (Perkin Elmer Spectrum GX Range: 30-
15600 cm-1) 
X-ray diffractometer (Diffractometer (powder) Philips Xpert MPD Range 
(2θ)) 
 
Method  
The materials for this study were kidney stones surgically recovered 
from patients. The stones removed during surgery were washed 
carefully with distilled water and dried over silica gel for several days 
and transferred into a plastic envelope bearing the sample number. 
Kidney stones were cut into quarters using a jeweler’s saw and were 
sent for FTIR spectroscopy (Fig. 5.1) to LAL Laboratories, New Delhi 
and to the SICART, Vallabh Vidhyanagar for X ray diffraction (n=100). 
The x-ray diffraction pattern (Fig 5.1-5.4) and FTIR spectrum (Fig 5.5-
5.8) were analyzed by study of d-spacing (Table 5.1) and characteristic 
IR frequencies (Table 5.2) for identification of the composition of the 
renal calculi. Percentage of different type of renal calculi present in 
saurashtra region was evaluated (Fig 5.9). 
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5.3 RESULT AND DISCUSSION 
The chemical composition of renal stones reflects their etiology. The 
therapy for the renal stone disease is based on chemical composition 
of calculi because it helps proper management of the disease and also 
prevention of its reoccurrence. 
 
D-spacing and relative intensities of X-ray diffraction pattern (Figure 
5.1-5.3) of renal calculi collected were compared with the standard 
mineral data (Table 5.1). Major IR bands of sampled renal calculi 
(Figure 5.4-5.7) were matched with IR spectrum of standard calcium 
oxalate monohydrate, calcium oxalate dehydrate, uric acid.etc. given in 
table 5.2  
 
In the chemical analysis of kidney stones it was observed that 75% 
were of calcium oxalate monohydrate and dihydrate type, 13 % stones 
were of uric acid type, 7% of them were of carbonate apatite type , 1% 
is of calcium hydrogen phosphate type and 4% stones were of other 
type. Fig. 5.8 The analysis of the composition of kidney stone showed 
that majority of stones prevalent in Saurashtra region was of calcium 
oxalate type. 
Hyperoxaluria is a risk factor for renal stones, and the urine load of 
oxalate plays a pivotal role in calcium-oxalate stone formation even in 
normocalciuric patients (Seftel et al., 1990). In normal individuals, the 
majority of urinary oxalate is derived from the endogenous metabolism 
of glycine, glyoxylate, and ascorbic acid, and 10 to 20% is derived from 
oral ingestion (Balaji et al., 1997). The colon is the major site of oxalate 
absorption, with 3 to 5% of dietary oxalate being absorbed under 
normal conditions (Balaji et al., 1997). However, an increased intestinal 
absorption of oxalate may lead to hyper oxaluria with a significantly 
enhanced risk of urinary stone formation (Chadwick et al., 1973; 
Earnest, 1979; Smith et al., 1972). A study performed on a population 
of idiopathic calcium oxalate stone formers with mild hyper oxaluria 
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found no evidence of any appreciable alteration in the renal oxalate 
transport, and concluded that an increased dietary load of oxalate with 
a possible hyper absorption was the responsible mechanism (Sutton et 
al., 1994). The relative amounts of calcium and oxalate in the diet may 
be an important variable in determining the rate of oxalate absorption 
and urinary excretion. The population of the patient is great consumer 
of leafy vegetables, peanuts and tea. Stones recovered from those 
were calcium oxalate containing in majority (75%). We found a 
relatively low percentage (3.4%) of patients who developed pure uric 
acid stones. Urinary crystallization studies (Breslau et al., 1988) 
revealed that the animal protein diet, when its electrolyte composition 
and quantity of protein were kept the same as for the vegetarian diet, 
conferred an increased risk for uric acid stones, but, because of 
opposing factors, not for calcium oxalate or calcium phosphate stones. 
In spite of calcium and oxalate are key responsible factor for the stone 
formation and reoccurrence of renal calculi in saurashtra region many 
other factors should also be considered. 
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Figure 5.2 X-ray diffraction patterns of Uric acid renal calculi. 
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Figure 5.3 X-ray diffraction patterns of Calcium oxalate  
 monohydrate renal calculi. 
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Figure 5.4 FTIR spectrum of renal calculi containing mixture of  
     calcium oxalate monohydrate, dihydrate and carbonate    
     apatite as main components. 
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Figure 5.5 FTIR spectrum of renal calculi containing mixture of   
      calcium oxalate monohydrate, dihydrate and uric acid  
      as main components. 
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Figure 5.6 FTIR spectrum of renal calculi containing mixture of  
     Calcium oxalate monohydrate and dihydrate as main 
     components. 
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Figure 5.7 FTIR spectrum of renal calculi containing uric acid as 
     main component. 
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Figure 5.8 Percentage prevalence of type of kidney stone 
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Table 5.1: Comparison of observed X-ray diffraction pattern with 
the standard data from mineral data 
 
TYPE OF KIDNEY 
STONE 
X-RAY DIFFRACTION 
PATTERN OBSERVED  
X-RAY DIFFRACTION 
PATTERN STANDARD 
FROM MINEARAL DATA 
 D-
SPACIN
G  
RELATIVE 
INTENSITY 
D-
SPACING  
RELATIVE 
INTENSITY 
CALCIUM 
HYDROGEN 
MONOHYDRATE 
5.930 100 5.930 100 
3.650 70 3.650 70 
2.966 45 2.966 45 
CALCIUM 
HYDROGEN 
DIHYDRATE 
6.185 100 6.180 100 
4.420 76 4.420 65 
2.778 33 2.775 30 
URIC ACID 3.095 100 3.093 100 
3.188 48.21 3.180 55 
3.849 47.87 3.87 69 
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Table 5.2 Characteristic group present with it’s FTIR bands 
observed for different types of renal calculi. 
 
Type of stone Principle IR band 
observed  
Characteristic group present 
Calcium 
oxalate 
monohydrate 
Grouping of five 
bands between 
3477-3047 cm-1 
Symmetric and asymmetric O-
H stretch 
1620 cm-1 C=O stretch 
1320 cm-1 C-O stretch 
885 cm-1 C-C stretch 
662 cm-1 Out of plane O-H bending 
781 cm-1 Out of plane C-H bending 
517 cm-1 In-plane O-C-O bending 
Calcium 
oxalate 
dihydrate 
Broad band at 3000 
cm-1 
Dihydrate form of CaOX 
1620 cm-1 C=O stretch 
1320 cm-1 C-O stretch 
885 cm-1 C-C stretch 
662 cm-1 Out of plane O-H bending 
Uric acid 1637.29  C=C stretching  
1018.13 N-H  stretching 
Carbonate 
appetite 
850, 1414, 1457 cm-
1 
CO3-2 
Calcium 
hydrogen 
phosphate 
1010 cm-1 PO4-3 
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6. EFFECT OF URINARY ELECTROLYTES ON CALCIUM  
    OXALATE CRYSTALLIZATION  
 
6.1 INTRODUCTION  
 
In spite of substantial progress in the pathophysiology and treatment of 
urolithiasis, there is no satisfactory drug to use in clinical therapy. Advances in 
techniques have left very few indications for open surgical extraction of 
urinary stone currently. These advances notwithstanding the search continue 
for medical approaches to urinary stone management. 
 
Low sodium diet and increased potassium diet is advised to patients of kidney 
stones. It is reported that kidney stones have repeatedly been produced in 
magnesium deficient animals (Hodkinson, 1958). Total serum magnesium and 
erythrocyte magnesium levels may be low in recurrent stone formers 
(Schmiedl et al., 1996). Perhaps 5% of stone formers have hypomagnesiuria 
(Preminger et al., 1989). The urine of over 25% of stone formers has lowered 
magnesium to calcium ratio (Labeeuw, 1987).  
 
The hypomagnesiuria appears to be due to inadequate magnesium intake, as 
magnesium absorption following supplementation appears to be normal 
(Johansson, 1980). Supplementation with magnesium salts may inhibit stone 
formation, even in patients without magnesium deficiency (Johansson, 1982). 
Magnesium decreases the urinary saturation of calcium oxalate by combining 
with urinary oxalate to form soluble magnesium oxalate (Goldwasser, 1986) 
so long as it is administered with meal (Lindberg, 1990).  
 
Most kidney stones contain calcium oxalate CaOx (Dyer et al., 1967) and the 
formation of urinary calculi involves a CaOx crystallization process that 
includes nucleation, growth and the aggregation of crystals (Leusmann et al., 
1995; Lieske et al., 1999). 
 
The study includes effect of ionic strength and mean activity co-efficient of 
different urinary electrolytes like potassium chloride, sodium chloride and 
magnesium sulfate on CaOx crystallization. 
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In this in vitro study, the effect and prospect of urinary electrolyte 
concentration in urological calcium oxalate calculi growth has been studied. 
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6.2 EXPERIMENTAL 
 
Material  
All the chemicals used were of A.R. grade. 
 
Reagent preparation 
1] Artificial urine (AU): 14.1g NaCl, 2.8g KCl, 17.3g Urea, 1.9g 25%v/v 
ammonia solution, 0.6g CaCl2, 0.43g MgSO4, 1.1672g Creatinine, 0.56g 
Hipuric acid and 0.6672g Uric acid dissolved in 0.02M HCl. Volume was 
adjusted to 1 liter and pH was adjusted between 5.5 to 6.5. 
 
2] 0.1M Sodium oxalate in distilled water: 13.4g Sodium oxalate dissolved 
in distilled water and volume is adjusted to 1L. 
 
3] 0.1M Sodium chloride in AU: 4g Sodium chloride dissolved in AU and 
volume is adjusted to 1L. 
 
4] 0.1M Potassium chloride in AU: 7.45g Potassium chloride dissolved in 
AU and volume is adjusted to 1L. 
 
5] 0.1M Magnesium sulfate in AU: 12g Magnesium sulfate dissolved in AU 
and volume is adjusted to 1L. 
 
Instruments and apparatus used 
Shimadzu UV Visible Spectrophotometer 1800 
Systronics Flame Photometer -128 
Olympus Magnus, MIPS 
Class A volumetric glass wares 
 
Method 
Nucleation and aggregation of CaOx crystals from artificial urine, containing 
each potassium chloride, sodium chloride and magnesium sulfate at different 
ionic strength, were studied by addition of 0.1 M Sodium oxalate.  
 
Experimental protocol  
CaOx precipitation induced by adding 40 µl of 0.1 M Sodium oxalate per ml of 
AU (corresponding to 0.536 mg) every 30 min (0, 30, 60 and 90 min) under 
shaking at 37°c, resulting in a final concentration of 2.14 mg sodium 
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oxalate/ml of AU in presence of varying concentration of different electrolytes 
,. Three sets were prepared according to table 6.1: 
 
Table 6.1        Volume of AU and electrolyte solutions mixed: 
 Set 1 Set 2 Set 3 
Sr. 
no. 
AU 
ml 
0.1M Sodium 
chloride solution  
ml 
0.1M Potassium 
chloride solution  
ml 
0.025M Magnesium 
sulfate solution  
ml 
C 20 0 0 0 
1 18 2 2 2 
2 16 4 4 4 
3 14 6 6 6 
4 12 8 8 8 
5 10 10 10 10 
 
 
After 90 minutes the test tube content mixed well and the content of each test 
tube divided into two sets A and B.  
 
OD at 620 nm determined with set A within 2 minutes using UV visible 
spectrophotometer.  
 
Contents of set B were centrifuged at 1500 rpm for 10 min. Calcium ion 
content was determined in supernatant by Flame Photometer. The residue 
containing the crystals of CaOx homogenized. One drop was transferred on to 
microscopic slide and size of the crystals was measured using stage 
micrometer technique. Images of the crystals were recorded with a digitalized 
video camera. 
Effect of ionic strength of different constituents of urine on CaOx crystal 
formation was plotted vs OD620, Calcium ion concentration and size of CaOx 
crystals. (Figure 6.1-6.3) 
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Statistical analysis 
The data obtained were expressed as mean ± SD. Results for control and 
experimental samples were analyzed statistically by ONE WAY ANOVA 
method. P values of less than 0.0001 were considered as statistically 
significant. This was followed by Multiple Turkey’s t-test, using graph pad 
prism version 5.0. 
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6.3 RESULT AND DISCUSSION  
In set A OD at 620nm increases with formation of CaOx crystals. But with 
increase in ionic strength of Potassium chloride, Sodium chloride and 
Magnesium sulfate from 0.01 to 0.05, OD at 620nm was less as compared to 
control. Comparatively in solution of Magnesium sulfate (Table 6.3) OD 
observed at 620nm was less than that of Sodium chloride (Table 6.4) and 
Potassium chloride (Table 6.5) at equal ionic strength (Figure 6.1). Thus the 
increase in ionic strength decreased CaOx crystal growth.  
 
In the set B the calcium ion concentration in supernatant determined by flame 
photometer it was observed that the calcium ion concentration increases with 
increase in ionic strength. Comparatively Calcium ion concentration in 
supernatant is more in set of Magnesium sulfate (Table 6.6) then in sodium 
chloride (Table 6.7) then in potassium chloride (Table 6.8) for each ionic 
strength (Figure 6.2). The increase in Calcium ion concentration in 
supernatant liquid suggests increases in solubility of CaOx crystals.  
 
The fractions of set B were also analyzed for the size of the CaOx crystals. 
Size of CaOx crystals produced were found decreased with increase in ionic 
strength for all, but the relative size at each ionic strength was increasing in 
order of sets of Magnesium sulfate(Table 6.9) to Sodium chloride (Table 6.10) 
to Potassium chloride (Table 6.11) (Figure 6.3). Images illustrate the effect of 
different urinary electrolytes on size of CaOx crystal (Images 6.1-6.3). 
 
Statistical analysis by comparison of variables of each electrolyte at all levels 
shows significant difference (P<0.05) (Table 6.2).Multiple Turkey’s t-test 
concluded that difference is significant at all ionic strength level (P<0.0001). 
 
Decrease in OD at 620nm and size of CaOx crystals with increase in ionic 
strength suggest that solubility of CaOx increases with increase in electrolyte 
concentration / ionic strength. Calcium ion concentration increased in 
supernatant (soluble form) with increase in ionic strength of different 
electrolyte supports the above observation. Comparison of effect of 
Potassium chloride, Sodium chloride and Magnesium sulfate for all the 
parameters suggest that Magnesium sulfate increases solubility of CaOx 
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crystals highest then was Sodium chloride and Potassium chloride in 
decreasing order. 
 
In dilute solutions of nonelectrolytes, activities and concentrations are 
considered to be practically identical, since electrostatic forces do not bring 
about deviations from ideal behavior in the solutions. Likewise, for weak 
electrolytes that are present alone in solution, the differences between the 
ionic concentration terms and activities are usually disregarded in ordinary 
calculations, since the number of ions present is small and the electrostatic 
forces are negligible. 
 
However, for strong electrolytes and for solutions of weak electrolytes 
together with salts and other electrolytes, such as exist in buffer systems, it is 
important to use activities instead of concentrations. The activity co-efficient 
and hence the activity, may be obtained by using one of the forms of the 
Debye – Huckel equation. According to the Debye-Huckel theory, the activity 
coefficient (γi) of an ion of valence zi is given by the expression: 
logγi=  -Azi2 √µ 
This equation yields a satisfactory measure of the activity coefficient of an ion 
species up to ionic strength of about 0.02. For water at 25ºc A= 0.5, as it 
depends only on temperature and dielectric constant of the medium. For 
binary electrolytes:  
log γ± =  -Az+z- √µ  where, z+ and z- are valences or charge. 
µ = ½ Σ1icizi2 
where, Σ1I = product of cz2 terms for all the ionic species in the solution 
from the i to e jth species are to be added together 
 ci = mol ions/L 
 zi= valence 
 
Activity coefficient of all strong electrolyte of a single class, for eg. all uni-
univalent electrolytes are approximately the same at a definite ionic strength, 
for dilute solution. 
 
For slightly soluble salts Ksp = [Ca2+][Ox2-].  
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Salts having no ion in common with the slightly soluble electrolyte produce an 
effect opposite to that of a common ion. At moderate concentration they 
increase rather than decrease the solubility because it lowers the mean molar 
ionic activity co-efficient of sparingly soluble salts. The true thermodynamic 
constant is activity product constant rather than solubility constant. 
Kap = a Ca2+  . a Ox2-  
where   aCa2+ = [Ca2+] [γ Ca2+]    and     aOx2-= [Ox2-] γ Ox2- 
Hence Kap =  [Ca2+][Ox2-] . γ±2  
            Kap  =  Ksp  . γ±2   
            Ksp = Kap / γ±2 
Solubility = [Ca2+] = [Ox2-] = √ Ksp = Kap / γ± 2 (Martin, 2001) 
 
This theory suggests that as the ionic strength of uncommon electrolyte 
increases the activity co-efficient decreases, which ultimately increases the 
solubility of sparingly soluble salts. 
 
As the ionic strength of the electrolyte increase in artificial urine the solubility 
of sparingly soluble salt CaOx increases. More over Magnesium sulfate 
increases the solubility of CaOx greater than potassium chloride and sodium 
chloride, can be explained by the equation;  
log γ± =  -Az+z- √µ,  in which z+z- for Magnesium sulfate  is 4, while for other 
two salts it is 1. Which explains that at equal molar concentration in 
Magnesium sulfate solution the mean molar activity coefficient of ions is less 
compared to the others so, Magnesium sulfate increases the solubility of 
CaOx crystals to a greater extent than other two salts. 
 
Conclusion 
Hence any electrolyte cation which form soluble compound with oxalate can 
increase solubility of CaOx by decreasing mean molar ionic activity coefficient 
of calcium with increasing ionic strength of solution. Study suggest that more 
the electrolyte concentration of salt having no common ion with CaOx less the 
nucleation and aggregation of CaOx crystals. Thus, urinary electrolytes can 
potentially increase solubility of CaOx crystals and may represent an 
attractive natural alternative for the prevention/cure of lithiasis of urinary tract. 
 
CHAPTER-6                               EFFECT OF URINARY ELECTROLYTES ON   
                                         CALCIUM OXALATE CRYSTALLIZATION 
 
Page 140 
 
 
 
 
Figure 6.1 Inhibition of CaOx crystallization in AU by electrolytes  
        estimated by measuring OD at 620nm   
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Figure 6.2    Solubility of CaOx crystals in AU in the presence of  
           electrolytes measured by calcium ion concentration (µg/ml)  
 
 
 
 
 
 
 
 
 
 
 
CHAPTER-6                               EFFECT OF URINARY ELECTROLYTES ON   
                                         CALCIUM OXALATE CRYSTALLIZATION 
 
Page 142 
 
Figure 6.3 Inhibition of CaOx crystallization in AU measured by size of 
        CaOx crystals. 
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Image 6.1  
 
 
 
 
Image 6.2  
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Image 6.3  
 
 
 
Image: 6.1-6.3 400x magnification 
Light microscopy of CaOx crystals induced in AU by adding sodium 
oxalate solution at 0.04 ionic strength in the presence of MgSO4 (image 
6.1),  NaCl (image 6.2) and KCl (image 6.3)  
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Table 6.2  Statistical analysis of results by one way ANOVA. 
 
Electrolyte 
added  
Variables evaluated n Fcal Difference 
(P<0.0001) 
MgSO4 
(Control 
and 
different 
ionic 
strength) 
Calcium ion 
concentration (µg/ml) 
6 1.084e+006 
 
Significant 
OD620 6 2448 
 
Significant 
Size 6 853639 
 
Significant 
NaCl 
(Control 
and 
different 
ionic 
strength) 
Calcium ion 
concentration (µg/ml) 
6 424349 
 
Significant 
OD620 6 23799 Significant 
 
Size 6 463924 
 
 
Significant 
KCl 
(Control 
and 
different 
ionic 
strength) 
Calcium ion 
concentration (µg/ml) 
6 324253 
 
Significant 
OD620 6 24006 
 
Significant 
Size 6 192470 
 
Significant 
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Table 6.3 Crystal growth measured at OD620nm in the set of MgSO4 (n=6). 
Sr. no. Ionic 
strength 
MeanOD620 ± Standard 
deviation 
1 0 0.640 0.0053 
2 0.01 0.465 0.0055 
3 0.02 0.360 0.0065 
4 0.03 0.350 0.0063 
5 0.04 0.330 0.0065 
6 0.05 0.325 0.005 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
 
 
 
 
 
Table 6.4 Crystal growth measured at OD620nm in the set of NaCl (n=6). 
Sr. no. Ionic 
strength 
MeanOD620 ± Standard 
deviation 
1 0 0.640 0.0053 
2 0.01 0.480 0.0076 
3 0.02 0.390 0.0074 
4 0.03 0.370 0.0097 
5 0.04 0.365 0.0055 
6 0.05 0.360 0.0065 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
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Table 6.5 Crystal growth measured at OD620nm in the set of KCl (n=6). 
Sr. no. Ionic 
strength 
Mean OD620 ± Standard 
deviation 
1 0 0.640 0.0053 
2 0.01 0.510 0.0067 
3 0.02 0.435 0.0063 
4 0.03 0.392 0.0071 
5 0.04 0.377 0.0108 
6 0.05 0.381 0.0093 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
 
 
 
Table 6.6 Calcium ion concentration (μg/ml) in the supernatant, in the 
set of MgSO4 (n=6). 
Sr. no. Ionic 
strength 
Mean Calcium ion 
concentration (μg/ml) 
± Standard 
deviation 
1 0 6803 11.8265 
2 0.01 7312 11.961 
3 0.02 7763 11.7757 
4 0.03 8015 10.477 
5 0.04 8360 10.5151 
6 0.05 8558 9.2177 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 explain to 
me 
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Table 6.7 Calcium ion concentration (μg/ml) in the supernatant, in the 
set of NaCl (n=6). 
Sr. no.  Ionic 
strength 
Mean Calcium ion 
concentration (μg/ml) 
± Standard 
deviation 
1 0 6803 8.3046 
2 0.01 7039 8.2704 
3 0.02 7282 8.0416 
4 0.03 7521 9.9197 
5 0.04 7762 8.6429 
6 0.05 7966 7.8081 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
 
 
 
 
Table 6.8 Calcium ion concentration (μg/ml) in the supernatant, in the 
set of KCl (n=6). 
Sr. no. Ionic 
strength 
Mean Calcium ion 
concentration (μg/ml) 
± Standard 
deviation 
1 0 6804 10.6536 
2 0.01 6961 9.6073 
3 0.02 7162 8.9889 
4 0.03 7281 9.0037 
5 0.04 7561 9.4657 
6 0.05 7681 9.2014 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
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Table 6.9 Size of Calcium oxalate crystals measured in micrometer in the 
set of MgSO4 (n=6). 
Sr. no. Ionic 
strength 
Mean micrometer ± Standard 
deviation 
1 0 30.9 5.47 
2 0.01 21.3 5.45 
3 0.02 20.4 5.8 
4 0.03 18.9 6.45 
5 0.04 15.6 5.16 
6 0.05 13.5 5.3 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
 
 
 
 
Table 6.10 Size of Calcium oxalate crystals measured in micrometer in 
the set of NaCl (n=6). 
Sr. no. Ionic 
strength 
Meanmicrometer ± Standard 
deviation 
1 0 30.9 5.47 
2 0.01 26.4 8.83 
3 0.02 25.95 8.71 
4 0.03 25.65 8.77 
5 0.04 19.2 6.5 
6 0.05 13.65 3.73 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
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Table 6.11 Size of Calcium oxalate crystals measured in micrometer in 
the set of KCl (n=6). 
Sr. no. Ionic 
strength 
Meanmicrometer ± Standard 
deviation 
1 0 30.9 5.47 
2 0.01 27.45 5.45 
3 0.02 22.2 6.3 
4 0.03 20.25 7.5 
5 0.04 20.1 7.72 
6 0.05 19.95 7.55 
All values represent Mean and ± SD, n=6 in each group,  P<0.001 
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7. EFFECT OF CHELATING AGENTS ON SOLUBILITY 
   OF CALCIUM OXALATE 
 
7.1 EFFECT OF CHELATING BIOMOLECULES ON SOLUBILITY OF 
CALCIUM OXALATE: AN IN VITRO STUDY  
 
7.1.1 INTRODUCTION 
Urinary citrate appears to be an important factor in the crystallization process 
of calcium oxalate and calcium phosphate. The urinary excretion of citrate 
was found to be significantly lower in patients with calcium oxalate stone 
disease as compared with normal subjects, and about 30 per cent of the 
calcium stone formers can be considered as hypocitraturic (Tiselius et al., 
1993). Citric acid irrigation was used in treatment of struvite stone (Joshi et 
al., 2001). 
 
Hyperoxaluria is a major risk factor for renal stones, and in most cases, it 
appears to be sustained by increased dietary load or increased intestinal 
absorption. Previous studies have shown that components of the endogenous 
digestive microflora, in particular Oxalobacter formigenes, utilize oxalate in the 
gut, thus limiting its absorption. Oxaluria can be reduced by means of 
reducing intestinal absorption through feeding a mixture of freeze-dried lactic 
acid bacteria (Campieri et al., 2001). 
 
Chelation therapy is now a days expanding its applications in various 
treatments. Iron chelating therapy used for treatment of thalassemia (Olivieri 
et al., 1997). Metal chelation therapy in Alzheimer’s disease (House et al., 
2004; Cuajungco et al., 2006) and in atherosclerosis (Ernst et al., 1997; 
Rathmann et al., 1984). Calcium chelation citric acid and lactic acid can play a 
major role in chelation therapy of naphrolithiasis. So, in this study, we analyze 
the effect and prospect of chelating agents in urological calcium oxalate 
calculi dissolution. 
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7.1.2 EXPERIMENTAL 
 
Material 
All the chemicals used were of A.R. Grade. 
Whatman filter paper 
 
Reagent preparation 
1] Artificial urine (AU): 14.1g NaCl, 2.8g KCl, 17.3g Urea, 1.9g 25%v/v 
ammonia solution, 0.6g CaCl2, 0.43g MgSO4, 1.1672g Creatinine, 0.56g 
Hipuric acid and 0.6672g Uric acid dissolved in 0.02M HCl. Volume was 
adjusted to 1 liter and pH was adjusted between 5.5 to 6.5. 
 
2] 0.1M Citric acid in AU: 19.2g Citric acid dissolved in AU and volume is 
adjusted to 1L. 
 
3] 0.1M Lactic acid in AU:9g Lactic acid dissolved in AU and volume is 
adjusted to 1L. 
 
Instruments and apparatus used 
Remi magnetic stirrer 5MLH plus 
Systronics Flame Photometer-128 
Class A glassware  
 
Method  
In two sets citric acid and lactic acid, 0.1M citric acid and 0.1M lactic acid 
prepared in artificial urine and artificial urine were mixed as given in the table 
7.1.1. 500mg calcium oxalate was added to each. The mixture is stirred using 
magnetic stirrer for 15 minutes at 37° C. The suspension was filtered with 
Whatman filter paper no.40. The change in calcium ion concentration was 
determined relative to control. Difference in calcium ion concentration in μg/ 
ml was determined against increase in molar concentration of chelating 
agents using flame photometer monitored. 
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Table 7.1.1 Volume of AU and chelate solutions mixed: 
 Set 1 Set 2 
Sr. no. Concentration 
of chelating 
agents 
AU 
ml 
0.1M Citric acid 
solution 
ml 
0.1M Lactic acid 
solution 
ml 
C 0 25 0 0 
1 0.01M 22.5 2.5 2.5 
2 0.02M 20 5 5 
3 0.03M 17.5 7.5 7.5 
4 0.04M 15 10 10 
5 0.05M 12.5 12.5 12.5 
6 0.06M 10 15 15 
7 0.07M 7.5 17.5 17.5 
 
Statistical analysis  
One way ANOVA was performed to test variation between samples and 
variation within the samples. 
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7.1.3 RESULT AND DISCUSSION 
As the concentration of citric acid and lactic acid increases the Calcium ion 
concentration in soluble form increases (Figure 7.1.1) (Table 7.1.1 and 7.1.2). 
This study shows that citric acid and lactic acid increase the solubility of 
calcium oxalate crystals. Comparison of both the plot Calcium ion conc. Vs 
molar conc. of citric acid and of lactic acid shows that lactic acid increases the 
solubility more than the citric acid. Statistical analysis of data with F test 
shows calculated F value is larger than tabulated F, a significant difference in 
response to dissolution with citric acid and lactic acid at df=1 between sample 
and df = 10 within samples, P = 0.05 
 
Citric acid is an organic and natural component of many fruits .It is also a 
chelating agent which produces soluble calcium citrate complex. Calcium 
citrate can be easily removed from body while accumulation of calcium 
oxalate forms kidney stone. This chelating property can be used to dissolve 
kidney stone.  
 
Hyper oxaluria is a major risk factor for renal stones, and in most cases, it 
appears to be sustained by increased dietary load or increased intestinal 
absorption. Previous studies have shown that components of the endogenous 
digestive microflora, in particular Oxalobacter formigenes, utilize oxalate in the 
gut, thus limiting its absorption.  
 
Lactic acid is a good chelating agent which produces soluble calcium lactate 
complex by reacting with dietary calcium. Calcium lactate a soluble complex 
of calcium can easily excreted from body. This chelating property can be used 
to dissolve kidney stone. Lactic acid is the main constituent of butter milk.  
 
The effect of lactic acid is quite better than citric acid (Figure: 7.1.1). These 
are the normal constituent of vegetarian food habitants. We can include both 
of these natural chelating agents in our routine food habits. These by forming 
sequester with calcium ion prevent the formation of calcium oxalate in the 
kidney.  
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Conclusion 
Citrus fruits are used in the treatment/ prevention of renal calculi. Lactic acid 
or lactate salts can be an alternative treatment for dissolution of renal calculi 
and may prove better than citric acid. 
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Figure 7.1.1 The solubility of CaOx crystals in AU in the presence of  
  chelating biomolecules  
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Table 7.1.2 Calcium ion concentration (μg/ml) in the set of Citric acid 
(n=6) 
Sr. 
no. 
Molar 
Concentration of 
Citric acid 
Mean Calcium ion 
concentration 
(μg/ml) 
± Standard 
deviation 
1 0 63.33 3.4448 
2 0.01 77.33 3.3266 
3 0.02 84.17 3.7638 
4 0.03 87.17 5.1153 
5 0.04 89.83 4.3089 
6 0.05 94.17 2.9268 
7 0.06 98.67 2.6583 
8 0.07 101.33 3.6696 
 
 
 
Table 7.1.3 Calcium ion concentration (μg/ml) in the set of Lactic acid 
(n=6) 
Sr. 
no. 
Molar 
Concentration of 
Lactic acid 
Mean Calcium ion 
concentration 
(μg/ml) 
± Standard 
deviation 
1 0 224.33 3.6147 
2 0.01 285.67 4.1311 
3 0.02 299.67 4.0331 
4 0.03 349.00 2.8284 
5 0.04 365.83 4.1190 
6 0.05 400.00 6.0663 
7 0.06 420.33 5.0859 
8 0.07 440.83 3.5449 
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7.2  EFFECT OF DISODIUM EDETATE ON SOLUBILITY OF CALCIUM 
 OXALATE: AN IN VITRO STUDY  
 
7.2.1 INTRODUCTION  
Chelation therapy is a controversial therapy that is administered by 
approximately 2,000 to 3,000 physicians in the U.S. It consists of the 
intravenous infusion of a solution containing ethylene diaminetetraacetic acid 
(EDTA), a synthetic amino acid, as well as vitamins, minerals, and other 
substances. The one- to three-hour treatments (depending on the dose) are 
administered to a patient who sits comfortably in an easy chair, reading, 
talking, watching TV or even sleeping. The treatments are administered as 
often as several times per week to as infrequently as one every other month, 
depending on the degree of illness and the patient's length of previous 
treatment. Usually a course of twenty to thirty treatments are adequate to 
reverse significant blockages, whereupon the patient is put on a less frequent 
maintenance regimen. (Chappell et al., 1993, 1994; Hancke  et al., 1993) 
 
EDTA was synthesized in Germany in 1935, and first patented in the U.S. in 
1941. Its first uses were in industry as a chelating agent, as an anticoagulant 
for clinical laboratory use, and as a treatment for lead poisoning. In 1955, Dr. 
Norman Clarke, then Director of Research of Providence Hospital in Detroit, 
Michigan, reported on his use of intravenous EDTA to dissolve what he 
referred to as "metastatic calcium"; (i.e., calcium that has been deposited 
where it was not wanted, as in arteries [atherosclerosis], joints [arthritis], 
kidneys [kidney stones], and the bony ossicular system in the ears 
[otosclerosis]), with generally favorable results.  
 
Disodium EDTA is mostly used internally as a chelating agent to remove 
toxins from body. It is used in iron chelating therapy used for treatment of 
thalassemia (Olivieri et al., 1997). Metal chelation therapy in Alzheimer’s 
disease (House et al., 2004; Cuajungco et al., 2006) and in atherosclerosis 
(Ernst et al., 1997; Rathmann et al.,1984). EDTA has been used o dissolve 
calcium phosphate calculi in invitro analysis (Xiang-bo  et al. 2005). 
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This chelating property can also be used to dissolve kidney stone. As being 
ligand it can bind with Calcium ions and can dissolve kidney stones. 
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7.2.2 EXPERIMENTAL 
 
Material 
All the chemicals used were of A.R. Grade. 
Whatman filter paper 
 
Reagent preparation 
1] Artificial urine (AU): 14.1g NaCl, 2.8g KCl, 17.3g Urea, 1.9g 25%v/v 
ammonia solution, 0.6g CaCl2, 0.43g MgSO4, 1.1672g Creatinine, 0.56g 
Hipuric acid and 0.6672g Uric acid dissolved in 0.02M HCl. Volume was 
adjusted to 1 liter and pH was adjusted between 5.5 to 6.5. 
 
2] 0.025M Disodium edentate in AU: 9.3g Disodium edetate dissolved in AU 
and volume is adjusted to 1L. 
 
Instruments and apparatus used 
Remi magnetic stirrer 5MLH plus 
Systronics Flame Photometer-128 
Class A glassware  
 
Method 
0.025 M Disodium edetate prepared in artificial urine and artificial urine are 
mixed as given in the table 7.2.1.Two drops of ammonia buffer is added in 
each. 500mg calcium oxalate is added to each. The mixture is stirred using 
magnetic stirrer for 15 minutes at 37° C. The suspension is filtered with 
Whatman filter paper. Calcium ioncontent was measured using flame 
photometer. The change in calcium ion concentration is determined relative to 
control. Difference in calcium ion concentration in μg/ ml is plotted against 
increase in molar concentration (Figure 7.2.1)  (Table 7.2.2). 
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Table 7.2.1 Volume of AU and Disodium edetate solutions mixed: 
Sr. no. Concentration of 
chelating agent 
AU ml 0.025M Disodium 
edetate solution 
ml 
C 0 25 0 
1 0.0025M 22.5 2.5 
2 0.0050M 20 5 
3 0.0075M 17.5 7.5 
4 0.0100M 15 10 
5 0.0125M 12.5 12.5 
6 0.0150M 10 15 
7 0.0175M 7.5 17.5 
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7.2.3 RESULT AND DISCUSSION 
Disodium edetate is the chelating agent used in many therapies from long 
time. Disodium edetate was added in increasing concentrations in the 
different sets of AU containing same amount of calcium oxalate. The 
concentration of calcium ion determined using flame photometer in the 
filtrate showed that the concentration of calcium ion increases with the 
increase in the concentration of Disodium edetate Fig.7.2.1, Table 7.2.2. 
This suggests that solubility of calcium oxalate increases with increasing 
the concentration of the chelating agent disodium edetate. The solubility 
increases better in basic media in presence of ammonia than alone with 
Disodium edetate. So this chelating agent works in basic condition. 
 
It is synthetic chelating agent, so the dose should be maintain to avoid its 
other side effects. It cannot be included in routine food habit.  
Conclusion 
Disodium edetate in different formulation in basic condition could be used 
in the treatment of renal calculi. 
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Figure 7.2.1The solubility of CaOx crystals in AU in the presence of  
      increasing amount of Disodium edentate measured by  
      calcium ion concentration. 
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Table 7.2.2 Calcium ion concentration (μg/ml) in the filtrate in the set of 
Disodium edetate (n=6). 
Sr. no. Molar 
Concentration of 
Disodium edetate 
Mean Calcium ion 
concentration 
(μg/ml) 
± Standard 
deviation 
1 0 50.17 3.8166 
2 0.0025M 108.83 6.1779 
3 0.0050M 249.67 6.5929 
4 0.0075M 320.00 5.4772 
5 0.0100M 352.17 4.4907 
6 0.0125M 380.33 6.8313 
7 0.0150M 399.83 6.7946 
8 0.0175M 420.17 4.4460 
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8. EFFECT OF pH ON SOLUBILITY OF CALCIUM 
   OXALATE: AN IN VITRO STUDY 
 
8.1 INTRODUCTION 
Majority types of stones prevalent are calcium oxalate, calcium phosphate, 
uric acid and struvite. All have different chemical composition. Solubility of all 
depends on various parameters. Urinary pH plays an important role in the 
solubility of kidney stones. Idiopathic Calcium oxalate stone formers and 
Calcium phosphate stone formers both are hyper calciuric, but Calcium 
phosphate stone formers produce urine of higher pH, which favors Calcium 
phosphate crystallization by increasing the abundance of urine mono 
hydrogen phosphate (pka ~ 6.7), the ion that combines with calcium (Parks et 
al., 2004). Dissolution of uric acid calculi with systemic alkalization obtained 
with intravenous infusion (Kursh et al., 1984). Intravenous sodium lactate 
provides rapid urinary alkalization and is effective in relief of obstruction by 
dissolution of uric acid calculi (Libert et al., 1985). 
 
pH plays an important role in dissolution of many ionozens. Study of effect of 
pH on solubility of calcium oxalate is still to be lightening on. Determinations 
of composition of kidney stones show that calcium oxalate is the major 
component present. In present study attempt has been made to understand 
effect of pH on solubility of calcium oxalate crystals in vitro. pH range selected 
for the study was the urinary pH range 4.5 to 8. Urine becomes acidic when 
as the amount of sodium and excess acid retained by the body increases. 
Alkaline urine, usually containing bicarbonate-carbonic acid buffer, is normally 
excreted when there excess of base or alkali in the body (Fischbach et al., 
2009). 
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8.2 EXPERIMENTAL 
 
Material  
Calcium oxalate monohydrate AR 
Anhydrous sodium carbonate AR 
Hydrochloric acid IP 
All the chemicals used for the preparation of artificial urine were of AR grade 
and urine was prepared in double distilled water. 
 
Reagent preparation 
1] Artificial urine (AU): 14.1g NaCl, 2.8g KCl, 17.3g Urea, 1.9g 25%v/v 
ammonia solution, 0.6g CaCl2, 0.43g MgSO4, 1.1672g Creatinine, 0.56g 
Hipuric acid and 0.6672g Uric acid dissolved in 0.02M HCl. Volume was 
adjusted to 1 liter and pH was adjusted between 5.5 to 6.5. Store in 
refrigerator. 
2] 0.5M Hydrochloric acid: as per IP 2010 
3] Carbonate buffer 
 
Instruments and apparatus used 
Systronics pH meter 335 
Remi magnetic stirrer 5MLH plus 
Systronics Flame Photometer-128 
Class A volumetric glass wares 
 
Method 
Solubility of CaOx crystals in artificial urine of different pH in carbonate buffer 
was studied. Artificial urine was prepared and stored according to the 
instruction. 
 
Experimental protocol  
50-50ml artificial urine was taken in eight 100ml beaker. 50mg of anhydrous 
Sodium carbonate was added to each. Electrodes of pH meter were dipped in 
the beaker. 0.5M HCl was added by burette to the beakers in such a way that 
the pH adjusted to 8, 7.5, 7, 6.5, 6, 5.5, 5 and 4.5 in respective beakers. To 
each solution 500mg of calcium oxalate monohydrate was added. The 
contents of beaker were stirred on the magnetic stirrers for 15 minutes, 
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maintaining the temperature 37˚C. The content was filtered using Whatman 
filter paper no. 40. Calcium ion present in soluble form in the filtrates was 
estimated using flame photometer, using standard calibration curve (n=6) 
(Table 8.1). pH vs. calcium ion concentration was plotted (Figure 8.1).  
 
Statistical analysis 
The results were estimated statistically using standard deviation (n=6). 
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8.3 RESULT AND DISCUSSION 
 
Calcium oxalate monohydrate is insoluble form of calcium responsible for 
aggregation and crystal growth leads to kidney stone formation. The factors 
which convert insoluble form to soluble form leads to dissolution of kidney 
stone. Solubility study of calcium oxalate monohydrate in different pH buffers 
indicated that the solubility of the crystals increases at lower pH. Calcium ion 
concentration in the filtrate remained constant from pH 8 to 6.5. Solubility of 
calcium oxalate increases from pH 6 and significant increased at pH 4.5 
(Table 1). (Figure 8.1).  
 
At acidic pH calcium oxalate converted to oxalic acid and calcium chloride, 
both are the soluble form. Making the pH acidic can increase the solubility. 
With medication if pH of urine could be decreased the treatment becomes 
more efficient. 
 
Present results suggest scope in the treatment particularly for calcium oxalate 
calculi which is the major type of kidney stone prevalent in Saurashtra region 
and also in all over the world. 
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Figure 8.1 Solubility of Calcium oxalate monohydrate crystals at  
      different pH in AU determined by Calcium ion  
      concentration using flame photometer (n=6). 
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Table 8.1 Calcium ion concentration in AU measured using flame 
photometer at various pH (carbonate buffer) (n=6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sr. no. pH Mean calcium ion 
concentration 
(µg/ml) 
± Standard deviation 
1 8 152 2.97 
2 7.5 162 3.76 
3 7 159 5.49 
4 6.5 157 4.24 
5 6 172 3.41 
6 5.5 188 8.57 
7 5 219 7.32 
8 4.5 335 7.59 
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9. SUMMARY 
 
 
Analysis of risk factors in people of Saurashtra suggested that 20 to 40 years 
age group was having high risk of kidney stone formation.  
 
Men (89%) were more susceptible to kidney stone formation than women 
(11%). People having weight 51 to 60 kg were having high risk of kidney 
stone formation. People working on daily wages or farmers (hard working) 
develop kidney stone easily.  
 
People drinking more water per day were very less in the kidney stone 
patients. Less water consumption was one of the risk factor. 
 
Food which increases kidney stone formation like peanuts, whole potato, tea 
and peanut oil is exceedingly consumed in Saurashtra. These may lead to 
kidney stone formation.  
 
Tobacco with lime is greatly consumed by the people of Saurashtra. The oral 
chewing of it could be the major reason for more prevalence of kidney stone 
in this region and especially in men, as they are more habituated then women.  
 
UTI infection and GIT disorder were the other diseases related to these 
patients. Statistical analysis of these risk factors by chi square test showed 
significant difference at P=0.05 level of significance indicate higher risk factors 
for  kidney stone formation. Risk factor analysis of patients of kidney stone of 
Saurashtra region magnified some of the aspects of kidney stone formation. 
The risk factors can be categorized in to clusters manageable and 
unmanageable. Weight, food, water, medication and habituation could be 
manageable, while age, gender and other diseases are unmanageable. 
Occupation could be/ could not be manageable.  
 
Determination of composition of stones by FT-IR spectroscopy and X-Ray 
diffraction techniques enlighten that stones recovered from the patients of 
Saurashtra region were calcium oxalate in majority (75%). It was found that 
relatively low percentage (3.4%) of patients developed uric acid stones. 
 
Total ionic strength of urine is important aspect considered in the 
crystallization of CaOx. CaOx in presence of electrolytes having no common 
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ion exhibited increased solubility with increasing ionic strength of solution by 
decreasing mean molar ionic activity coefficient of calcium. Magnesium gave 
more effective prevention of crystallization than others. Thus, urinary 
electrolytes could potentially increase solubility of CaOx crystals and may 
represent an attractive natural alternative for the prevention/cure of lithiasis of 
urinary tract. 
 
Citric acid is an organic and natural component of many fruits and fruit juices. 
It is also a good chelating agent which produces soluble complex calcium 
citrate by reacting with calcium. Calcium citrate can be easily removed from 
body while accumulation of calcium oxalate forms kidney stone. This chelating 
property can be used to dissolve kidney stone. Lactic acid is a good chelating 
agent which produces soluble complex calcium lactate by reacting with dietary 
calcium. Calcium lactate a soluble complex of calcium can easily be removed 
from body. This chelating property can be used to dissolve kidney stone. 
Lactic acid is the main constituent of butter milk. The effect of lactic acid was 
quite better than citric acid. It was the normal constituent of our routine food 
habit in saurashtra. We can include both of these natural chelating agents in 
our routine food habits. Statistical analysis of data with F test shows 
calculated F value is larger than tabulated F, a significant difference in 
response to dissolution with citric acid and lactic acid at df =1 between sample 
and df = 10 within samples, P = 0.05. 
 
Disodium edetate can form soluble complexes with calcium and magnesium 
ion in basic condition. It can be worked on for treatment of calcium oxalate 
stone therapy.  
 
Urinary pH could be the major factor for the occurrence and reoccurrence of 
the renal calculi. With other treatments if urinary pH is also maintain on 
relatively acidic side dissolution and prevention of calculi could be helped. 
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ABBREVIATIONS 
AU  Artificial Urine 
BBM   Brush Border Membrane  
CaOx   Calcium Oxalate 
CaP  Calcium Phosphate 
CaSR  Calcium-Sensing Receptor  
cIMCD Continuous Inner Medullary Collecting Duct  
COD  Calcium Oxalate Dihydrate  
COM  Calcium Oxalate Monohydrate 
CT  Computed Tomography  
DHA   Decosahexaenoic Acid  
DNA  Deoxyribonucleic Acid  
EPA  Eicosapentaenoic Acid  
ESWL  Extracorporeal Shock Wave Lithotripsy  
FTIR  Fourier Transform Infrared Spectroscopy 
GBM  Glomerular Basement Membrane  
GIT   Gastro Intestinal Tract  
 HA  Hyaluronan  
HA  Hyaluronic Acid 
iRTA  Idiopathic Renal Tubular Acidosis  
IS  Ionic Strength  
IVU  Intravenous Urogram  
NC  Nephrocalcin  
nTHP  Normal Tamm-Horsfall Protein 
OPN   Osteopontin 
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PC  Phosphatidylcholine 
PCNL  Percutaneous Nephrolithotomy  
PE  Phosphatidylethanolamine  
 PI  Phophatidylinositol  
PS  Phosphatidylserine 
PTF1  Prothrombin F1  
RMS   Route Mean Square 
RTA  Renal Tubular Acidosis  
SF-THP Stone Former Tamm-Horsfall Protein  
TDS   Total Dissolved Solid 
THP  Tamm-Horsfall protein  
UTI  Urinary Tract Infection 
VDR  Vitamin D Receptor 
XRD   X Ray Diffraction  
OD   Optical Density 
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PUBLICATIONS 
 
INVENTI RAPID: CLINICAL RESEARCH 
 
Patel PB, Vadalia KR. Effect of urinary electrolytes on calcium oxalate 
crystallization: an in vitro study. Inventi Rapid: Clinical Research. 
publication date: 2011/8/10 
 
ABSTRACT 
Urolithiasis is affecting 10-12% of the population in industrialized countries. 
The reoccurrence rate is also high. Ionic strength and activity coefficient are 
the untouched terms in concern of urolithiasis. In the present study, we 
evaluated the effect of ionic strength of different urinary electrolytes on CaOx 
crystallization in vitro. CaOx precipitation was induced by the addition of 0.1M 
sodium oxalate to artificial urine (n=5) in presence of urinary electrolytes in 
increasing ionic strength order and in absence of urinary electrolyte (control). 
The presence of CaOx crystals was evaluated immediately by determining 
OD at 620 nm, size of crystals and Calcium ion concentration. The results 
saw inhibitory effect of urinary electrolytes on CaOx crystal growth in artificial 
urine, suggesting that ionic strength may increase the solubility of CaOx 
crystals by reducing mean molar activity co-efficient, Statistical analysis by 
comparison of variables of each electrolyte at all levels shows significant 
difference (P<0.05). Multiple Turkey’s t-test concluded that difference is 
significant at all ionic strength level (P<0.0001). Electrolyte therapy could be 
used as an alternative form of treatment. The same can be utilized for the 
prevention of urolithiasis. 
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INTERNATIONAL JOURNAL OF DRUG FORMULATION AND RESEARCH 
 
Patel PB, Vadalia KR. Effect of pH on solubility of calcium oxalate: an in 
vitro study. IJDFR Jul-Aug 2011;2(4):290-5.  
 
ABSTRACT 
PH plays an important role in dissolution of any compound. Study of effect of 
pH on solubility of calcium oxalate is still to be enlightened. In present study 
attempt has been made to understand effect of pH on solubility of calcium 
oxalate crystals in vitro in buffers. pH range selected for the study was the 
urinary pH range 4.5 to 8. Solubility study of calcium oxalate monohydrate in 
different pH buffers indicate that the solubility of the crystals increases at 
lower pH. Present results suggest better mode of treatment particularly for 
calcium oxalate calculi which is the major type of kidney stone prevalent all 
over the world. 
 
Keywords: Calcium oxalate, pH, solubility, buffer 
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JOURNAL OF CHEMICAL AND PHARMACEUTICAL RESEARCH 
 
Patel PB, Vadalia KR. Effect of chelating biomolecules on solubility of 
calcium oxalate: An in vitro study. Journal of Chemical and 
Pharmaceutical Research 2011;3(5):491-5 
 
ABSTRACT 
Urinary citrate appears to be an important factor in the crystallization process 
of calcium oxalate and calcium phosphate. Oxaluria can be reduced by 
means of reducing intestinal absorption of oxalate through feeding a mixture 
of freeze-dried lactic acid bacteria. Chelation therapy is now a day’s 
expanding its applications in various treatments. Calcium chelation by citric 
acid and lactic acid can play a major role in chelation therapy of 
nephrolithiasis. So, in present study, we analyzed the effect and prospect of 
chelating agents in urological calcium oxalate calculi dissolution as around 
70% calculi are of calcium oxalate type. Present study concluded that as the 
concentration of citric acid and lactic acid increases the calcium ion 
concentration in soluble form increases. Statistical analysis of data with F test 
shows calculated F value is larger than tabulated F, a significant difference in 
response to dissolution with citric acid and lactic acid at df =1 between sample 
and df = 10 within samples, p = 0.05 
 
Keywords: Calcium oxalate, Citric acid, Lactic acid, Chelation therapy. 
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